The	O
functional	O
domains	O
of	O
the	O
murine	B-DNA
Thy-1	I-DNA
gene	I-DNA
promoter	I-DNA
.	O

The	O
Thy-1	B-DNA
gene	I-DNA
promoter	I-DNA
resembles	O
a	O
``	B-DNA
housekeeping	I-DNA
''	I-DNA
promoter	I-DNA
in	O
that	O
it	O
is	O
located	O
within	O
a	O
methylation-free	B-DNA
island	I-DNA
,	O
lacks	O
a	O
canonical	B-DNA
TATA	I-DNA
box	I-DNA
,	O
and	O
displays	O
heterogeneity	O
in	O
the	O
5'-end	B-RNA
termini	I-RNA
of	O
the	O
mRNA	B-RNA
.	O

Using	O
transgenic	O
mice	O
,	O
we	O
show	O
that	O
this	O
promoter	B-DNA
does	O
not	O
confer	O
any	O
tissue	O
specificity	O
and	O
is	O
active	O
only	O
in	O
a	O
position-dependent	O
manner	O
.	O

It	O
can	O
only	O
be	O
activated	O
in	O
a	O
tissue-specific	O
manner	O
by	O
elements	O
that	O
lie	O
downstream	O
of	O
the	O
initiation	B-DNA
site	I-DNA
.	O

We	O
have	O
analyzed	O
the	O
functional	O
domains	O
of	O
the	O
minimal	B-DNA
Thy-1	I-DNA
promoter	I-DNA
and	O
show	O
that	O
the	O
dominant	B-DNA
promoter	I-DNA
elements	I-DNA
consist	O
of	O
multiple	B-DNA
binding	I-DNA
sites	I-DNA
for	O
the	O
transcription	B-protein
factor	I-protein
Sp1	B-protein
,	O
an	O
inverted	O
CCAAT	B-DNA
box	I-DNA
,	O
and	O
sequences	O
proximal	O
to	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
.	O

DNase	O
I	O
and	O
gel	O
mobility	O
shift	O
assays	O
show	O
the	O
binding	O
of	O
a	O
number	O
of	O
nuclear	B-protein
factors	I-protein
to	O
these	O
elements	B-DNA
,	O
including	O
Sp1	B-protein
and	O
CP1	B-protein
.	O

Our	O
results	O
show	O
that	O
the	O
structure	O
of	O
this	O
promoter	B-DNA
only	O
permits	O
productive	O
interactions	O
of	O
the	O
two	O
transcription	B-protein
factors	I-protein
Sp1	B-protein
and	O
CP1	B-protein
with	O
the	O
basal	O
transcription	O
machinery	O
in	O
the	O
presence	O
of	O
enhancer	B-DNA
sequences	I-DNA
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
Biology	NULL
,	NULL
Apr	NULL
.	NULL

1991	NULL
,	NULL
p.	NULL
2216-2228	NULL
0270-7306/91/042216-13	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1991	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

11	NULL
,	NULL
No	NULL
.	NULL

4	NULL
The	NULL
Functional	NULL
Domains	NULL
of	NULL
the	NULL
Murine	NULL
Thy-/	NULL
Gene	NULL
Promoter	NULL
EUGENIA	NULL
SPANOPOULOU	NULL
,	NULL
VINCENT	NULL
GIGUERE	NULL
,	NULL
t	NULL
anp	NULL
FRANK	NULL
GROSVELD*	NULL
Laboratory	NULL
of	NULL
Gene	NULL
Structure	NULL
and	NULL
Expression	NULL
,	NULL
National	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
The	NULL
Ridgeway	NULL
,	NULL
Mill	NULL
Hill	NULL
,	NULL
London	NULL
NW7	NULL
IAA	NULL
,	NULL
United	NULL
Kingdom	NULL
Received	NULL
18	NULL
September	NULL
1990/Accepted	NULL
21	NULL
December	NULL
1990	NULL
The	NULL
Thy-1	NULL
gene	NULL
promoter	NULL
resembles	NULL
a	NULL
``	NULL
housekeeping	NULL
``	NULL
promoter	NULL
in	NULL
that	NULL
it	NULL
is	NULL
located	NULL
within	NULL
a	NULL
methylation-free	NULL
island	NULL
,	NULL
lacks	NULL
a	NULL
canonical	NULL
TATA	NULL
box	NULL
,	NULL
and	NULL
displays	NULL
heterogeneity	NULL
in	NULL
the	NULL
5'-end	NULL
termini	NULL
of	NULL
the	NULL
mRNA	NULL
.	NULL

Using	NULL
transgenic	NULL
mice	NULL
,	NULL
we	NULL
show	NULL
that	NULL
this	NULL
promoter	NULL
does	NULL
not	NULL
confer	NULL
any	NULL
tissue	NULL
specificity	NULL
and	NULL
is	NULL
active	NULL
only	NULL
in	NULL
a	NULL
position-dependent	NULL
manner	NULL
.	NULL

It	NULL
can	NULL
only	NULL
be	NULL
activated	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
by	NULL
elements	NULL
that	NULL
lie	NULL
downstream	NULL
of	NULL
the	NULL
initiation	NULL
site	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
the	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
minimal	NULL
Thy-7	NULL
promoter	NULL
and	NULL
show	NULL
that	NULL
the	NULL
dominant	NULL
promoter	NULL
elements	NULL
consist	NULL
of	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
Sp1	NULL
,	NULL
an	NULL
inverted	NULL
CCAAT	NULL
box	NULL
,	NULL
and	NULL
sequences	NULL
proximal	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

DNase	NULL
I	NULL
and	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
show	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
number	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
these	NULL
elements	NULL
,	NULL
including	NULL
Sp1	NULL
and	NULL
CP1	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
structure	NULL
of	NULL
this	NULL
promoter	NULL
only	NULL
permits	NULL
productive	NULL
interactions	NULL
of	NULL
the	NULL
two	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
CPI	NULL
with	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
enhancer	NULL
sequences	NULL
.	NULL

The	NULL
murine	NULL
Thy-1	NULL
antigen	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
immunoglob-ulin	NULL
superfamily	NULL
,	NULL
is	NULL
a	NULL
cell	NULL
surface	NULL
glycoprotein	NULL
anchored	NULL
on	NULL
the	NULL
membrane	NULL
through	NULL
a	NULL
phospholipid	NULL
tail	NULL
(	NULL
47	NULL
,	NULL
66	NULL
,	NULL
70	NULL
)	NULL
.	NULL

In	NULL
the	NULL
mouse	NULL
,	NULL
Thy-1	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
the	NULL
neuronal	NULL
and	NULL
lymphoid	NULL
systems	NULL
(	NULL
55	NULL
,	NULL
57	NULL
,	NULL
70	NULL
)	NULL
,	NULL
being	NULL
found	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
all	NULL
neurons	NULL
,	NULL
in	NULL
which	NULL
it	NULL
represents	NULL
a	NULL
terminal	NULL
differentiation	NULL
marker	NULL
(	NULL
54	NULL
)	NULL
.	NULL

In	NULL
the	NULL
lymphoid	NULL
system	NULL
,	NULL
Thy-1	NULL
is	NULL
present	NULL
at	NULL
high	NULL
levels	NULL
on	NULL
most	NULL
cortical	NULL
thymocytes	NULL
and	NULL
mature	NULL
T	NULL
lympho-cytes	NULL
.	NULL

This	NULL
expression	NULL
pattern	NULL
is	NULL
the	NULL
result	NULL
of	NULL
both	NULL
tissue-specific	NULL
and	NULL
developmental	NULL
regulation	NULL
exerted	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
44	NULL
,	NULL
62	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
is	NULL
located	NULL
within	NULL
a	NULL
methylation-free	NULL
,	NULL
CpG-rich	NULL
island	NULL
(	NULL
HTF	NULL
island	NULL
)	NULL
(	NULL
4	NULL
)	NULL
and	NULL
lacks	NULL
a	NULL
canonical	NULL
TATA	NULL
box	NULL
(	NULL
23	NULL
)	NULL
,	NULL
features	NULL
which	NULL
are	NULL
found	NULL
often	NULL
in	NULL
'	NULL
``	NULL
housekeeping*	NULL
``	NULL
*	NULL
'	NULL
gene	NULL
promoters	NULL
(	NULL
18	NULL
)	NULL
but	NULL
less	NULL
frequently	NULL
in	NULL
tissue-specific	NULL
genes	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Initiation	NULL
of	NULL
transcription	NULL
occurs	NULL
from	NULL
multiple	NULL
sites	NULL
the	NULL
distribution	NULL
of	NULL
which	NULL
differs	NULL
in	NULL
murine	NULL
brain	NULL
and	NULL
thymus	NULL
(	NULL
62	NULL
)	NULL
.	NULL

In	NULL
apparent	NULL
contrast	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
tissue	NULL
specificity	NULL
and	NULL
its	NULL
housekeeping	NULL
characteristics	NULL
,	NULL
the	NULL
Thy-/	NULL
gene	NULL
promoter	NULL
is	NULL
nevertheless	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
tissue-specific	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
,	NULL
located	NULL
80	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
start	NULL
site	NULL
(	NULL
62	NULL
)	NULL
.	NULL

By	NULL
using	NULL
transgenic	NULL
mice	NULL
,	NULL
a	NULL
number	NULL
of	NULL
Thy-/	NULL
transcriptional	NULL
elements	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
early	NULL
thymocytes	NULL
is	NULL
controlled	NULL
by	NULL
enhancer	NULL
sequences	NULL
located	NULL
within	NULL
the	NULL
murine	NULL
third	NULL
intron	NULL
(	NULL
67	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
thymocyte-specific	NULL
enhancer	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
maintain	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
,	NULL
which	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
distinct	NULL
regulatory	NULL
sequences	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
Thy-/	NULL
gene	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
neuronal	NULL
cells	NULL
is	NULL
dictated	NULL
by	NULL
cis-acting	NULL
sequences	NULL
present	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
first	NULL
intron	NULL
(	NULL
7	NULL
,	NULL
67	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
tissue-specific	NULL
and	NULL
developmental	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
is	NULL
achieved	NULL
through	NULL
separate	NULL
elements	NULL
which	NULL
function	NULL
independently	NULL
of	NULL
each	NULL
other	NULL
and	NULL
are	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
principal	NULL
site	NULL
of	NULL
initiation	NULL
.	NULL

Experiments	NULL
in	NULL
transgenic	NULL
mice	NULL
have	NULL
also	NULL
established	NULL
that	NULL
a	NULL
300-bp	NULL
region	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
(	NULL
-270	NULL
to	NULL
+36	NULL
)	NULL
contains	NULL
all	NULL
of	NULL
the	NULL
elements	NULL
required	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

+	NULL
Present	NULL
address	NULL
:	NULL
Division	NULL
of	NULL
Endocrinology	NULL
,	NULL
Hospital	NULL
for	NULL
Sick	NULL
Children	NULL
,	NULL
Toronto	NULL
,	NULL
Canada	NULL
NSG	NULL
1X8	NULL
.	NULL

2216	NULL
to	NULL
cooperate	NULL
with	NULL
the	NULL
downstream	NULL
tissue-specific	NULL
elements	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
hybrid	NULL
transgenes	NULL
in	NULL
which	NULL
the	NULL
Thy-/	NULL
promoter	NULL
was	NULL
replaced	NULL
by	NULL
different	NULL
heterologous	NULL
promoters	NULL
exhibited	NULL
a	NULL
tissue-specific	NULL
and	NULL
developmental	NULL
profile	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
Thy-/	NULL
gene	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
tissue-specific	NULL
hypersensitive	NULL
site	NULL
in	NULL
the	NULL
Thy-1	NULL
promoter	NULL
is	NULL
presumably	NULL
the	NULL
result	NULL
of	NULL
productive	NULL
interactions	NULL
between	NULL
the	NULL
promoter	NULL
and	NULL
distant	NULL
regulatory	NULL
factors	NULL
,	NULL
with	NULL
the	NULL
promoter	NULL
elements	NULL
acting	NULL
solely	NULL
as	NULL
the	NULL
mediators	NULL
rather	NULL
than	NULL
the	NULL
initiators	NULL
of	NULL
activation	NULL
.	NULL

This	NULL
scenario	NULL
constitutes	NULL
a	NULL
common	NULL
motif	NULL
underlying	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
different	NULL
genes	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
promoter	NULL
may	NULL
have	NULL
some	NULL
tissue-specific	NULL
components	NULL
to	NULL
allow	NULL
expression	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
define	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
Thy-	NULL
!	NULL

promoter	NULL
by	NULL
using	NULL
transgenic	NULL
mice	NULL
,	NULL
and	NULL
we	NULL
describe	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
functional	NULL
elements	NULL
required	NULL
for	NULL
activity	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
by	NULL
mutational	NULL
analysis	NULL
and	NULL
the	NULL
characterization	NULL
of	NULL
the	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
these	NULL
elements	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Preparation	NULL
of	NULL
the	NULL
hybrid	NULL
construct	NULL
and	NULL
analysis	NULL
of	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
hybrid	NULL
construct	NULL
,	NULL
microinjected	NULL
into	NULL
fertilized	NULL
mouse	NULL
oocytes	NULL
,	NULL
was	NULL
prepared	NULL
by	NULL
replacing	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
y-globin	NULL
gene	NULL
with	NULL
a	NULL
310-bp	NULL
SmaI-Pstl	NULL
fragment	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
corresponding	NULL
to	NULL
sequences	NULL
-270	NULL
to	NULL
+36	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Bg/lI	NULL
and	NULL
HindIII	NULL
linkers	NULL
were	NULL
inserted	NULL
in	NULL
the	NULL
Smal	NULL
and	NULL
PstI	NULL
sites	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
Bgill-HindlII	NULL
fragment	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
Ncol	NULL
site	NULL
present	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
human	NULL
y-globin	NULL
gene	NULL
by	NULL
means	NULL
of	NULL
a	NULL
HindIII	NULL
linker	NULL
inserted	NULL
in	NULL
this	NULL
site	NULL
.	NULL

DNA	NULL
fragments	NULL
were	NULL
isolated	NULL
free	NULL
of	NULL
vector	NULL
sequences	NULL
from	NULL
a	NULL
low-melting-point	NULL
agarose	NULL
gel	NULL
(	NULL
Sea-Plaque	NULL
)	NULL
after	NULL
phenol	NULL
extraction	NULL
.	NULL

Fertilized	NULL
oocytes	NULL
from	NULL
(	NULL
CBA	NULL
x	NULL
C57BL/10	NULL
)	NULL
F	NULL
,	NULL
mice	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
pronuclei	NULL
were	NULL
injected	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Transgenic	NULL
mice	NULL
were	NULL
identified	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
genomic	NULL
DNA	NULL
.	NULL

Total	NULL
mRNA	NULL
from	NULL
mouse	NULL
tissues	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
S1	NULL
nuclease	NULL
protection	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Construction	NULL
of	NULL
promoter	NULL
mutants	NULL
.	NULL

The	NULL
linker-scanning	NULL
(	NULL
LS	NULL
)	NULL
and	NULL
internal	NULL
deletion	NULL
(	NULL
ID	NULL
)	NULL
mutations	NULL
were	NULL
engineered	NULL
by	NULL
Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
joining	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
deletions	NULL
covering	NULL
the	NULL
promoter	NULL
region	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Construction	NULL
of	NULL
the	NULL
plasmid	NULL
(	NULL
pGSE628	NULL
)	NULL
containing	NULL
520	NULL
bp	NULL
of	NULL
the	NULL
mouse	NULL
Thy-/	NULL
5	NULL
'	NULL
region	NULL
fused	NULL
to	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
(	NULL
by	NULL
means	NULL
of	NULL
a	NULL
HindIII	NULL
linker	NULL
inserted	NULL
in	NULL
the	NULL
Psfl	NULL
site	NULL
of	NULL
the	NULL
Thy-/	NULL
first	NULL
exon	NULL
)	NULL
has	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Plasmid	NULL
pGSE668	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
pGSE628	NULL
in	NULL
which	NULL
part	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
region	NULL
was	NULL
deleted	NULL
by	NULL
excising	NULL
a	NULL
restriction	NULL
fragment	NULL
delineated	NULL
by	NULL
the	NULL
Clal	NULL
site	NULL
in	NULL
the	NULL
vector	NULL
and	NULL
the	NULL
Smal	NULL
site	NULL
in	NULL
the	NULL
Thy-	NULL
!	NULL

promoter	NULL
(	NULL
-270	NULL
bp	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
recircularized	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
Bg/lI	NULL
linker	NULL
.	NULL

Plasmids	NULL
pGSE628	NULL
and	NULL
pGSE668	NULL
were	NULL
linearized	NULL
by	NULL
digestion	NULL
with	NULL
Smal	NULL
and	NULL
HindIII	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
then	NULL
digested	NULL
with	NULL
exonuclease	NULL
BAl	NULL
31	NULL
.	NULL

DNA	NULL
samples	NULL
with	NULL
deletions	NULL
extending	NULL
to	NULL
the	NULL
desired	NULL
positions	NULL
in	NULL
the	NULL
promoter	NULL
were	NULL
then	NULL
introduced	NULL
into	NULL
plasmids	NULL
by	NULL
standard	NULL
procedures	NULL
.	NULL

The	NULL
recombi-nants	NULL
were	NULL
screened	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Clal	NULL
linker	NULL
,	NULL
and	NULL
the	NULL
selected	NULL
clones	NULL
were	NULL
sequenced	NULL
by	NULL
the	NULL
Maxam-Gilbert	NULL
method	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Matching	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
deletions	NULL
were	NULL
made	NULL
by	NULL
exchange	NULL
of	NULL
the	NULL
corresponding	NULL
Clal	NULL
and	NULL
HindIII	NULL
restriction	NULL
fragments	NULL
between	NULL
the	NULL
two	NULL
sets	NULL
of	NULL
plasmid	NULL
.	NULL

All	NULL
of	NULL
the	NULL
resulting	NULL
LS	NULL
or	NULL
ID	NULL
mutants	NULL
contain	NULL
277	NULL
bp	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
with	NULL
an	NULL
introduced	NULL
Cl/al	NULL
linker	NULL
between	NULL
positions	NULL
-120	NULL
and	NULL
+8	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

To	NULL
express	NULL
the	NULL
mutants	NULL
transiently	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
analyze	NULL
them	NULL
by	NULL
S1	NULL
nuclease	NULL
protection	NULL
,	NULL
the	NULL
CAT	NULL
gene	NULL
was	NULL
replaced	NULL
by	NULL
an	NULL
Ncol-HindIII	NULL
y-globin	NULL
fragment	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
which	NULL
contains	NULL
the	NULL
globin	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
site	NULL
,	NULL
while	NULL
pBR322	NULL
was	NULL
replaced	NULL
a	NULL
pBSV	NULL
vector	NULL
(	NULL
pBR328	NULL
BamHI-EcoRI	NULL
fragment	NULL
linked	NULL
to	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
[	NULL
SV40	NULL
]	NULL
BamHI-EcoRI	NULL
fragment	NULL
)	NULL
.	NULL

DNA-mediated	NULL
transfections	NULL
,	NULL
CAT	NULL
assays	NULL
,	NULL
and	NULL
S1	NULL
nuclease	NULL
protection	NULL
analysis	NULL
.	NULL

Transfections	NULL
into	NULL
L	NULL
cells	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Transfections	NULL
into	NULL
HeLa	NULL
cells	NULL
were	NULL
performed	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
S1	NULL
nuclease	NULL
protection	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
62	NULL
)	NULL
.	NULL

The	NULL
5'-end	NULL
S1	NULL
probes	NULL
were	NULL
a	NULL
Bg/lI-Bgll	NULL
360-bp	NULL
or	NULL
an	NULL
Xbal-Bgll	NULL
145-bp	NULL
fragment	NULL
labeled	NULL
at	NULL
the	NULL
Bg/I	NULL
site	NULL
.	NULL

Both	NULL
probes	NULL
protect	NULL
81-	NULL
to	NULL
86-bp	NULL
fragments	NULL
from	NULL
the	NULL
hybrid	NULL
transcripts	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
values	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
comparison	NULL
with	NULL
a	NULL
cotransfected	NULL
human	NULL
B-globin	NULL
plasmid	NULL
.	NULL

A	NULL
540-bp	NULL
Accl-Accl	NULL
5'-end	NULL
probe	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
the	NULL
human	NULL
B-globin	NULL
transcripts	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
suspension	NULL
to	NULL
a	NULL
density	NULL
0.6	NULL
x	NULL
10°	NULL
to	NULL
1.0	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

Conditions	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
for	NULL
HeLa	NULL
cells	NULL
and	NULL
by	NULL
Gorski	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
for	NULL
whole	NULL
mouse	NULL
brain	NULL
,	NULL
EL-4	NULL
,	NULL
and	NULL
K562	NULL
extracts	NULL
.	NULL

For	NULL
DNase	NULL
I	NULL
footprinting	NULL
assays	NULL
,	NULL
a	NULL
SmaI-PstI	NULL
fragment	NULL
representing	NULL
the	NULL
Thy-	NULL
]	NULL
promoter	NULL
region	NULL
-270	NULL
to	NULL
+36	NULL
(	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
pGEM4	NULL
vector	NULL
.	NULL

The	NULL
plasmid	NULL
was	NULL
linearized	NULL
with	NULL
either	NULL
EcoRI	NULL
or	NULL
HindIII	NULL
(	NULL
polylinker	NULL
sites	NULL
)	NULL
,	NULL
labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
recut	NULL
with	NULL
a	NULL
second	NULL
enzyme	NULL
,	NULL
and	NULL
isolated	NULL
from	NULL
a	NULL
preparative	NULL
gel	NULL
by	NULL
phenol	NULL
extraction	NULL
.	NULL

Binding	NULL
reactions	NULL
and	NULL
analysis	NULL
of	NULL
the	NULL
purified	NULL
DNA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

A	NULL
chemically	NULL
synthesized	NULL
single-stranded	NULL
oligonucleotide	NULL
was	NULL
**P	NULL
labeled	NULL
with	NULL
T4	NULL
kinase	NULL
;	NULL
after	NULL
separation	NULL
of	NULL
the	NULL
unincorporated	NULL
nucleotides	NULL
,	NULL
the	NULL
labeled	NULL
strand	NULL
was	NULL
annealed	NULL
to	NULL
a	NULL
fourfold	NULL
excess	NULL
of	NULL
the	NULL
nonlabeled	NULL
complementary	NULL
strand	NULL
.	NULL

Binding	NULL
reactions	NULL
and	NULL
analysis	NULL
on	NULL
a	NULL
native	NULL
acrylamide	NULL
gel	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
competition	NULL
assays	NULL
,	NULL
a	NULL
100-	NULL
to	NULL
200-fold	NULL
excess	NULL
of	NULL
cold	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

Sequences	NULL
of	NULL
oligonucleotides	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
gel	NULL
retarda-	NULL
DETAILED	NULL
ANALYSIS	NULL
OF	NULL
THE	NULL
MURINE	NULL
Thy-/	NULL
GENE	NULL
PROMOTER	NULL
2217	NULL
tion	NULL
assays	NULL
.	NULL

Sequences	NULL
of	NULL
probes	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
THY-A	NULL
,	NULL
5	NULL
!	NULL

-CGATTACCAACCCCACCCCCTGGAT-3	NULL
'	NULL
;	NULL
THY-B	NULL
,	NULL
5-CGATGGCCCCCCTCCATCCGTCAT-3	NULL
'	NULL
;	NULL
THY-C	NULL
,	NULL
5-C	NULL
GATGTCCATCCTTTTCCCTCGGAT-3	NULL
'	NULL
;	NULL
THY-D	NULL
,	NULL
5-CG	NULL
ATGTCTCAGCCTCCGATTCGAT-3	NULL
'	NULL
;	NULL
THY-E	NULL
,	NULL
5-CGAT	NULL
GCTGACCGATTGGCTGCACAT-3	NULL
'	NULL
;	NULL
THY-F	NULL
,	NULL
5-CGATCG	NULL
AGTCCCTCCCTGCTGATAT-3	NULL
'	NULL
;	NULL
THY-G	NULL
,	NULL
5-CGATTGCT	NULL
CCCCCCTCTCTCCCCACCCTAT-3	NULL
'	NULL
;	NULL
THY-H	NULL
,	NULL
5-CGAT	NULL
GGTGAAAACTGCGGGCTTCAGCGCTGGGTGCAGCA	NULL
ACAT-3	NULL
'	NULL
;	NULL
THY-K	NULL
,	NULL
5-CGATGGTGAAAACTGCGGGCTT	NULL
CAGCGCTGGGTGCCAT-3	NULL
'	NULL
;	NULL
THY-M	NULL
,	NULL
5-CGATAGCGCT	NULL
GGGTGCAGCAACTGGAGGCGTTGGCGAT-3	NULL
'	NULL
;	NULL
Spl	NULL
GC	NULL
ILIV	NULL
,	NULL
5-CGATGGGCGGAGTTAGGGGCGGGACTAT-3'Spl	NULL
GC	NULL
III	NULL
,	NULL
5-GATCCGAACTGGGCGGAGTTAGGG	NULL
GCA-3	NULL
'	NULL
;	NULL
Spl	NULL
mut	NULL
.	NULL

,	NULL
5-GATCCGAACTGGACTGAGTTAG	NULL
GGGCA-3	NULL
'	NULL
;	NULL
«	NULL
-globin	NULL
CCAAT	NULL
;	NULL
5-CTCCGCGCCAGCCAAT	NULL
GAGCGCCGCCC-3	NULL
'	NULL
;	NULL
and	NULL
adenovirus	NULL
NF-I	NULL
,	NULL
5-TATACCTT	NULL
ATTTTGGATTGAAGCCAATATGATTGC-3	NULL
'	NULL
.	NULL

Methylation	NULL
interference	NULL
assays	NULL
.	NULL

The	NULL
labeled	NULL
probes	NULL
were	NULL
methylated	NULL
as	NULL
described	NULL
by	NULL
Maxam	NULL
and	NULL
Gilbert	NULL
(	NULL
48	NULL
)	NULL
,	NULL
and	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
native	NULL
gel	NULL
.	NULL

Bands	NULL
containing	NULL
the	NULL
appropriate	NULL
complexes	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
and	NULL
electroeluted	NULL
.	NULL

The	NULL
nucleic	NULL
acid	NULL
was	NULL
purified	NULL
,	NULL
and	NULL
after	NULL
NaOH	NULL
treatment	NULL
(	NULL
48	NULL
)	NULL
,	NULL
the	NULL
radioactive	NULL
samples	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

RESULTS	NULL
Analysis	NULL
of	NULL
promoter	NULL
activity	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

A	NULL
complete	NULL
Thy-1	NULL
gene	NULL
containing	NULL
all	NULL
of	NULL
the	NULL
downstream	NULL
regulatory	NULL
elements	NULL
but	NULL
only	NULL
310	NULL
bp	NULL
of	NULL
promoter	NULL
sequences	NULL
shows	NULL
proper	NULL
tissue-	NULL
and	NULL
developmental	NULL
stage-specific	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
67	NULL
)	NULL
.	NULL

To	NULL
further	NULL
analyze	NULL
the	NULL
specificity	NULL
of	NULL
these	NULL
sequences	NULL
,	NULL
a	NULL
fragment	NULL
representing	NULL
the	NULL
promoter	NULL
region	NULL
between	NULL
-270	NULL
and	NULL
+36	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
y-globin	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
hybrid	NULL
construct	NULL
was	NULL
microinjected	NULL
into	NULL
fertilized	NULL
mouse	NULL
oocytes	NULL
,	NULL
and	NULL
six	NULL
transgenic	NULL
lines	NULL
carrying	NULL
different	NULL
copy	NULL
numbers	NULL
of	NULL
the	NULL
transgene	NULL
were	NULL
generated	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
adult	NULL
transgenic	NULL
tissues	NULL
and	NULL
assayed	NULL
by	NULL
S1	NULL
protection	NULL
analysis	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
Thy-/	NULL
gene	NULL
and	NULL
of	NULL
the	NULL
hybrid	NULL
transgene	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Transcripts	NULL
of	NULL
the	NULL
endogenous	NULL
gene	NULL
were	NULL
found	NULL
at	NULL
negligible	NULL
levels	NULL
in	NULL
the	NULL
kidney	NULL
and	NULL
liver	NULL
,	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
muscle	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lung	NULL
,	NULL
and	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
brain	NULL
and	NULL
thymus	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
transcripts	NULL
from	NULL
the	NULL
transgene	NULL
were	NULL
present	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
(	NULL
about	NULL
0.75	NULL
%	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
endogenous	NULL
levels	NULL
)	NULL
in	NULL
the	NULL
brain	NULL
of	NULL
three	NULL
of	NULL
six	NULL
lines	NULL
,	NULL
and	NULL
these	NULL
did	NULL
not	NULL
show	NULL
the	NULL
distribution	NULL
of	NULL
transcription	NULL
initiation	NULL
typical	NULL
for	NULL
brain	NULL
(	NULL
62	NULL
)	NULL
.	NULL

The	NULL
transgene	NULL
was	NULL
silent	NULL
in	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
tissues	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
line	NULL
Tr.4	NULL
(	NULL
containing	NULL
the	NULL
highest	NULL
number	NULL
of	NULL
copies	NULL
of	NULL
the	NULL
transgene	NULL
)	NULL
,	NULL
which	NULL
expressed	NULL
the	NULL
hybrid	NULL
gene	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
in	NULL
all	NULL
tissues	NULL
analyzed	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
the	NULL
Thy-/	NULL
promoter	NULL
is	NULL
an	NULL
extremely	NULL
weak	NULL
or	NULL
inactive	NULL
unit	NULL
which	NULL
has	NULL
no	NULL
tissue	NULL
specificity	NULL
and	NULL
functions	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
enhancer	NULL
sequences	NULL
as	NULL
previously	NULL
suggested	NULL
(	NULL
23	NULL
,	NULL
33	NULL
,	NULL
67	NULL
)	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
functional	NULL
elements	NULL
of	NULL
the	NULL
Thy-7	NULL
promoter	NULL
.	NULL

To	NULL
define	NULL
the	NULL
sequences	NULL
required	NULL
for	NULL
promoter	NULL
function	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
with	NULL
5'-terminal	NULL
endpoints	NULL
located	NULL
between	NULL
-489	NULL
and	NULL
-80	NULL
were	NULL
constructed	NULL
and	NULL
linked	NULL
onto	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
SV40	NULL
enhancer	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
mutants	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
B-globin	NULL
control	NULL
plasmid	NULL
into	NULL
L	NULL
cells	NULL
,	NULL
and	NULL
transcriptional	NULL
activity	NULL
was	NULL
determined	NULL
48	NULL
h	NULL
later	NULL
by	NULL
CAT	NULL
assays	NULL
and	NULL
S1	NULL
nuclease	NULL
protection	NULL
analysis	NULL
.	NULL

No	NULL
decrease	NULL
in	NULL
the	NULL
relative	NULL
2218	NULL
SPANOPOULOU	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
-.-	NULL
-a	NULL
Tks	NULL
.	NULL

:	NULL
_	NULL
;	NULL
Irs	NULL
_	NULL
;	NULL
.	NULL

Tr4	NULL
___	NULL
Tr	NULL
.	NULL

5	NULL
Tr.6	NULL
IB	NULL
T	NULL
S	NULL
K	NULL
LB	NULL
T	NULL
S	NULL
KLiLuM/|B	NULL
TK	NULL
LiLu	NULL
M||B	NULL
T	NULL
S	NULL
K	NULL
LiLuM/|B	NULL
T	NULL
S	NULL
KLi	NULL
M/B	NULL
T	NULL
S	NULL
K	NULL
Li	NULL
LuM/B	NULL
T	NULL
S	NULL
K	NULL
Li	NULL
Lu	NULL
M\	NULL
C+	NULL
C-	NULL
Mar	NULL
£	NULL
t	NULL
is	NULL
%	NULL
1	NULL
En	NULL
.	NULL

»	NULL
wet	NULL
cae	NULL
j	NULL
Tr	NULL
.	NULL

»	NULL
Tr	NULL
.	NULL

i	NULL
B	NULL
!	NULL

E	NULL
Aq	NULL
Som	NULL
pf	NULL
i	NULL
E	NULL
B	NULL
a	NULL
1	NULL
2	NULL
|	NULL
3	NULL
H	NULL
--	NULL
%	NULL
&	NULL
--	NULL
--	NULL
§Q	NULL
é	NULL
Thy	NULL
1	NULL
P	NULL
V	NULL
-	NULL
globin	NULL
<	NULL
4	NULL
e	NULL
®	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
as	NULL
analyzed	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
310-bp	NULL
fragment	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
(	NULL
-270	NULL
to	NULL
+36	NULL
)	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
y-globin	NULL
gene	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Six	NULL
individual	NULL
transgenic	NULL
lines	NULL
carrying	NULL
various	NULL
copy	NULL
numbers	NULL
of	NULL
the	NULL
transgene	NULL
were	NULL
generated	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
number	NULL
of	NULL
adult	NULL
tissues	NULL
and	NULL
analyzed	NULL
by	NULL
S1	NULL
nuclease	NULL
protection	NULL
using	NULL
three	NULL
different	NULL
probes	NULL
(	NULL
40	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
per	NULL
lane	NULL
)	NULL
.	NULL

Endogenous	NULL
Thy-/	NULL
transcripts	NULL
were	NULL
detected	NULL
by	NULL
a	NULL
680-bp	NULL
Sacl-Trh1111	NULL
probe	NULL
that	NULL
detects	NULL
a	NULL
244-bp	NULL
fragment	NULL
(	NULL
En	NULL
.	NULL
)	NULL

corresponding	NULL
to	NULL
the	NULL
5°	NULL
border	NULL
of	NULL
exon	NULL
IV	NULL
.	NULL

Transgenic	NULL
transcripts	NULL
were	NULL
assayed	NULL
by	NULL
both	NULL
a	NULL
S'-end	NULL
Bg/lI-Boi/l	NULL
probe	NULL
which	NULL
protects	NULL
75-	NULL
to	NULL
80-	NULL
bp	NULL
fragments	NULL
representing	NULL
multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
(	NULL
triplet	NULL
of	NULL
thin	NULL
arrows	NULL
,	NULL
Tr	NULL
.	NULL

;	NULL
lower	NULL
half	NULL
of	NULL
panel	NULL
A	NULL
)	NULL
and	NULL
a	NULL
3'-end	NULL
EcoRI-HindIII	NULL
520-bp	NULL
probe	NULL
which	NULL
detects	NULL
a	NULL
fragment	NULL
of	NULL
170	NULL
bp	NULL
corresponding	NULL
to	NULL
the	NULL
polyadenylation	NULL
site	NULL
of	NULL
the	NULL
exogenous	NULL
y-globin	NULL
gene	NULL
(	NULL
Tr	NULL
.	NULL
)	NULL

and	NULL
a	NULL
minor	NULL
polyadenylation	NULL
site	NULL
180	NULL
bp	NULL
further	NULL
downstream	NULL
(	NULL
350-bp	NULL
fragment	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
5°	NULL
probe	NULL
protects	NULL
a	NULL
nonspecific	NULL
band	NULL
in	NULL
the	NULL
normal	NULL
brain	NULL
lane	NULL
.	NULL

Lanes	NULL
are	NULL
designated	NULL
as	NULL
follows	NULL
:	NULL
brain	NULL
(	NULL
B	NULL
)	NULL
,	NULL
thymus	NULL
(	NULL
T	NULL
)	NULL
,	NULL
spleen	NULL
(	NULL
S	NULL
)	NULL
,	NULL
kidney	NULL
(	NULL
K	NULL
)	NULL
,	NULL
liver	NULL
(	NULL
Li	NULL
)	NULL
,	NULL
lung	NULL
(	NULL
Lu	NULL
)	NULL
,	NULL
and	NULL
muscle	NULL
(	NULL
M	NULL
)	NULL
.	NULL

C+	NULL
,	NULL
positive	NULL
control	NULL
representing	NULL
40	NULL
pg	NULL
of	NULL
total	NULL
mRNA	NULL
isolated	NULL
from	NULL
a	NULL
HeLa	NULL
cell	NULL
line	NULL
,	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
hybrid	NULL
transgene	NULL
linked	NULL
to	NULL
an	NULL
SV40	NULL
enhancer	NULL
;	NULL
C-	NULL
,	NULL
negative	NULL
control	NULL
(	NULL
40	NULL
ug	NULL
of	NULL
HeLa	NULL
total	NULL
mRNA	NULL
)	NULL
;	NULL
Mar	NULL
.	NULL

,	NULL
radiolabeled	NULL
marker	NULL
fragments	NULL
.	NULL

Tr.1	NULL
to	NULL
Tr.6	NULL
,	NULL
Transgenic	NULL
lines	NULL
;	NULL
Nor	NULL
.	NULL

,	NULL
a	NULL
nontransgenic	NULL
mouse	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
Thy-//y-globin	NULL
gene	NULL
hybrid	NULL
construct	NULL
,	NULL
analyzed	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Probes	NULL
used	NULL
for	NULL
S1	NULL
analysis	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

Restriction	NULL
sites	NULL
:	NULL
EcoRI	NULL
(	NULL
E	NULL
)	NULL
,	NULL
HindliI	NULL
(	NULL
H	NULL
)	NULL
,	NULL
BgilI	NULL
(	NULL
B	NULL
)	NULL
,	NULL
Be/l	NULL
(	NULL
Bl	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Genomic	NULL
DNA	NULL
obtained	NULL
from	NULL
the	NULL
transgenic	NULL
lines	NULL
was	NULL
digested	NULL
with	NULL
Sacl	NULL
,	NULL
subjected	NULL
to	NULL
Southern	NULL
blot	NULL
analysis	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
human	NULL
y-globin	NULL
probe	NULL
to	NULL
estimate	NULL
the	NULL
copy	NULL
number	NULL
of	NULL
the	NULL
integrated	NULL
transgenes	NULL
.	NULL

Transgenic	NULL
lines	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
;	NULL
estimated	NULL
copy	NULL
numbers	NULL
of	NULL
the	NULL
hybrid	NULL
construct	NULL
are	NULL
indicated	NULL
below	NULL
.	NULL

activity	NULL
(	NULL
RA	NULL
;	NULL
ratio	NULL
of	NULL
CAT	NULL
activity	NULL
to	NULL
B-globin	NULL
expression	NULL
)	NULL
was	NULL
observed	NULL
until	NULL
deletions	NULL
reached	NULL
position	NULL
-80	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
first	NULL
100	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
cap	NULL
site	NULL
are	NULL
essential	NULL
and	NULL
sufficient	NULL
for	NULL
efficient	NULL
initiation	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
mouse	NULL
Thy-/	NULL
promoter	NULL
.	NULL

To	NULL
define	NULL
the	NULL
regulatory	NULL
domains	NULL
of	NULL
the	NULL
minimal	NULL
Thy-/	NULL
promoter	NULL
,	NULL
a	NULL
number	NULL
of	NULL
mutants	NULL
were	NULL
produced	NULL
(	NULL
between	NULL
-120	NULL
and	NULL
+36	NULL
)	NULL
in	NULL
which	NULL
wild-type	NULL
Thy-/	NULL
sequences	NULL
were	NULL
either	NULL
substituted	NULL
or	NULL
deleted	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

To	NULL
increase	NULL
the	NULL
steady-state	NULL
mRNA	NULL
levels	NULL
of	NULL
the	NULL
hybrid	NULL
transcripts	NULL
,	NULL
the	NULL
various	NULL
promoter	NULL
mutants	NULL
were	NULL
linked	NULL
to	NULL
the	NULL
y-globin	NULL
gene	NULL
.	NULL

Constructs	NULL
were	NULL
transiently	NULL
expressed	NULL
either	NULL
in	NULL
L	NULL
cells	NULL
(	NULL
Thy-I/CAT	NULL
gene	NULL
hybrids	NULL
)	NULL
or	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Thy-1/y-globin	NULL
gene	NULL
hybrids	NULL
)	NULL
along	NULL
with	NULL
the	NULL
cotransfected	NULL
B-globin	NULL
control	NULL
plasmid	NULL
and	NULL
assayed	NULL
by	NULL
CAT	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
or	NULL
S1	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
sequences	NULL
between	NULL
-91	NULL
and	NULL
-77	NULL
,	NULL
-68	NULL
and	NULL
-48	NULL
,	NULL
and	NULL
-24	NULL
and	NULL
-10	NULL
are	NULL
essential	NULL
for	NULL
transcriptional	NULL
activation	NULL
,	NULL
since	NULL
mutations	NULL
in	NULL
these	NULL
three	NULL
regions	NULL
almost	NULL
abolish	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
other	NULL
regions	NULL
(	NULL
-41	NULL
to	NULL
-31	NULL
and	NULL
-1	NULL
to	NULL
+8	NULL
)	NULL
have	NULL
a	NULL
moderate	NULL
effect	NULL
on	NULL
promoter	NULL
activity	NULL
.	NULL

An	NULL
unexpected	NULL
result	NULL
is	NULL
the	NULL
high	NULL
RA	NULL
of	NULL
ID	NULL
-52/-31	NULL
,	NULL
since	NULL
LS	NULL
-41/-31	NULL
exhibits	NULL
only	NULL
40	NULL
%	NULL
of	NULL
wild-type	NULL
activity	NULL
.	NULL

This	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
negative	NULL
sequences	NULL
within	NULL
the	NULL
region	NULL
from	NULL
-52	NULL
to	NULL
-41	NULL
or	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
(	NULL
s	NULL
)	NULL
has	NULL
been	NULL
brought	NULL
close	NULL
to	NULL
the	NULL
proximal	NULL
promoter	NULL
.	NULL

Analysis	NULL
of	NULL
representative	NULL
mutants	NULL
by	NULL
S1	NULL
nuclease	NULL
protection	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
shows	NULL
the	NULL
heterogeneity	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
transcripts	NULL
and	NULL
establishes	NULL
the	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
.	NULL

Comparison	NULL
of	NULL
lanes	NULL
WT	NULL
(	NULL
270	NULL
bp	NULL
of	NULL
promoter	NULL
sequences	NULL
)	NULL
and	NULL
ID-120	NULL
(	NULL
120	NULL
bp	NULL
of	NULL
promoter	NULL
sequences	NULL
)	NULL
indicates	NULL
that	NULL
sequences	NULL
upstream	NULL
of	NULL
-101	NULL
are	NULL
dispensable	NULL
for	NULL
promoter	NULL
activity	NULL
in	NULL
both	NULL
HeLa	NULL
and	NULL
L	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
region	NULL
between	NULL
-101	NULL
and	NULL
-41	NULL
is	NULL
essential	NULL
for	NULL
transcription	NULL
efficiency	NULL
,	NULL
but	NULL
mutations	NULL
in	NULL
this	NULL
region	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
change	NULL
the	NULL
site	NULL
of	NULL
initiation	NULL
.	NULL

However	NULL
,	NULL
three	NULL
LS	NULL
mutations	NULL
in	NULL
the	NULL
region	NULL
from	NULL
-30	NULL
to	NULL
+8	NULL
show	NULL
decreased	NULL
expression	NULL
but	NULL
also	NULL
the	NULL
appearance	NULL
of	NULL
novel	NULL
start	NULL
sites	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
this	NULL
region	NULL
is	NULL
also	NULL
accentuated	NULL
by	NULL
internal	NULL
deletions	NULL
ID	NULL
-41/-19	NULL
,	NULL
-18/+8	NULL
,	NULL
and	NULL
-1/+36	NULL
.	NULL

Three	NULL
main	NULL
regions	NULL
were	NULL
identified	NULL
as	NULL
essential	NULL
for	NULL
efficient	NULL
2219	NULL
DETAILED	NULL
ANALYSIS	NULL
OF	NULL
THE	NULL
MURINE	NULL
GENE	NULL
PROMOTER	NULL
Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
wild	NULL
type	NULL
CD-116	NULL
CD-113	NULL
CD-101	NULL
CD-80	NULL
LS-120/-113	NULL
LS-118/-109	NULL
LS-110/-101	NULL
LS-97/-89	NULL
LS-91/-80	NULL
LS-83/-77	NULL
LS-71/-64	NULL
LS-68/-59	NULL
LS-59/-48	NULL
LS-41/-31	NULL
LS-24/-19	NULL
LS-18/-10	NULL
LS-1/48	NULL
10-120/-101	NULL
10-97/-77	NULL
10-83/-64	NULL
10-67/-48	NULL
10-52/-31	NULL
1D-41/-19	NULL
18/18	NULL
I0-1/+36	NULL
4	NULL
;	NULL
48	NULL
48	NULL
do	NULL
~80	NULL
-10	NULL
-60	NULL
+50	NULL
~40	NULL
~30	NULL
+20	NULL
-10	NULL
CAP	NULL
_	NULL
+10	NULL
+20	NULL
+30	NULL
1	NULL
I	NULL
1	NULL
1	NULL
|	NULL
I	NULL
I	NULL
I	NULL
I_	NULL
I	NULL
I	NULL
[	NULL
ACCACCCCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCECTCCCTGCTCCCCCCTCTCT	NULL
CCCCACCCCTGGTGAAAACTGCGGECTTCAGCGEC	NULL
TGGGTGCAGCAAC	NULL
TGEAGGCGT	NULL
TGGCGCAC	NULL
TAGGAGGAGGCTGCAG	NULL
qatgCCCCACCCCCTECATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTGCTCCCCCCTCTCTCCCCACCCCTGGTGAAAACTECGGGCTTCAGCGECTGEGGTGCAGCAACTGGAGGCGTTGGCGCACTAGGAGGAGGCTGCAG	NULL
AtCaatgCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTGCTCCCCCCTCTCT	NULL
CCCCACCCCTGGTGAAAACTECGGGCT	NULL
TCAGCGCTGGGTGCAGCAACTGGAGGCGT	NULL
TGGCGCACTAGGAGGAGGCTGCAG	NULL
~CatcgatgCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTGCTCCCCCCTCTCT	NULL
CCCCACCCCTGGTGAAAACTGCGGGECTTCAGCGCTGGGTGCAGCAACTGGAGGCGTTGGCGCAC	NULL
TAGGAGGAGGC	NULL
TGCAG	NULL
--	NULL
CaTCgatgTGGCTGAATCTAGAGTCCCTCCCTGCTCCCECCTCTCT	NULL
CCCCACCCCTGGTGAAAACTGCGGGCTTCAGCGCTGGGTGCAGCAACTGGAGGCGTTGGCGCAC	NULL
TAGGAGGAGGC	NULL
TGCAG	NULL
Engnnnaqngqﬂnzqqnﬂnqngnndnngﬂnnn325.332	NULL
“	NULL
?	NULL

nan-	NULL
”	NULL
22329223	NULL
CCCCACCCCTGGTGAAAACTGCGGGCTTCAGCECTGGGTGCAGCAACTGGAGGCGTTGGCGCACTAGGAGGAGGCTGCAG	NULL
ACCAK-CaAtgCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTGCTCCCCCCTCTCT	NULL
CCCCACCCCTGGTGAAAACTGCGGGCTTCAGCGCTGEGTGCAGCAACTGGAGGCGTTGECGCAC	NULL
TAGGAGGAGGC	NULL
TGCAG	NULL
ACCACCCCACCatCgatg-CCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTGCTCCCCCCTCTCT	NULL
CCCCACCCC	NULL
TGGTGAAAACTGCGGGECTTCAGCGCTGEGTGCAGCAACTGGAGGCGTTGGCGCAC	NULL
TAGGAGGAGGC	NULL
TGCAG	NULL
ACCACCCCACCCCCTCCATCCTTcatCqatgGCCTCCGATTGGCTGAATCTAGAGTCCCTECCTECTCCCCCCTCTCT	NULL
CCCCACCCCTGGTGAAAACTGCGGGCTTCAGCGCTGGGTGCAGCAACTGGAGGCGTTEGCECACTAGGAGGAGGCTGCAG	NULL
CCCCACCCCTGGTGAAAACTGCGGGECTTCAGCGCTGGGTGCAGCAACTGGAGGCGT	NULL
TGGCGCACTAGGAGGAGGC	NULL
TGCAG	NULL
>	NULL
nn	NULL
>	NULL
nnﬂn	NULL
>	NULL
nnnnnqnn	NULL
>	NULL
4nna3.2	NULL
“	NULL
nﬂqgnﬁnqnnhDHPmMmqngq-uggannnqnnnqnnqnnnnﬁnqﬂna	NULL
CCCCACCCCTGGTGAAAACTGCGGGCTTCAGCECTGGGTGCAGCAACTGGAGGCGTTGGCGCACTAGGAGGAGGCTGCAG	NULL
>	NULL
na	NULL
>	NULL
nnnn	NULL
>	NULL
nnnnnqnnﬁﬁniqqnnnqn	NULL
>	NULL
nn2nnn	NULL
>	NULL
3mnnangqhmhmbnbnnnunngnﬁqnnn9223	NULL
CECCACCCCTGGTGAAAACTGCGGGCTTCAGCGCTGGGTGCAGCAACTGGAGGCGTTGGCGCACTAGGAGGAGGCTGCAG	NULL
ACCACCCCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAcA-TCqaaTqCCTECTCCCCCCTCTCT	NULL
CCCCACCCC	NULL
TGGTGAAAACTGCGGGCT	NULL
TCAGCGCTGGGTECAGCAACTGGAGGCGT	NULL
TGGCGCACTAGGAGGAGGC	NULL
TGCAG	NULL
ACCACCCCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGECTGAATCTAGAGTCCCTCCaT-Cgatg	NULL
--	NULL
CTCTCT	NULL
CCCCACCCCTGGTGAAAACTECGGGCT	NULL
TCAGCECTGGGTGCAGCAACTGGAGGCGTTGGCGCAC	NULL
TAGGAGGAGGC	NULL
TGCAG	NULL
ACCACCCCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTECTCCCCCCTCTCT	NULL
C-	NULL
-CAtCqaTGGTGAAAACTECGGGCTTCAGCGCTGGGTGCAGCAACTGGAGGCGTTGGCGCAC	NULL
TAGGAGGAGEC	NULL
TGCAG	NULL
ACCACCCCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTECTCCCCCCTCTCT	NULL
nann	NULL
>	NULL
nnnnqnnqngnmbwgn3n	NULL
>	NULL
nnmn3m3nn	NULL
>	NULL
nnW	NULL
>	NULL
aAmman	NULL
?	NULL

aannnnn	NULL
>	NULL
nq	NULL
>	NULL
on	NULL
>	NULL
nn	NULL
>	NULL
nnnqnn	NULL
>	NULL
n	NULL
ACCACCCCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTEAATCTAGAGTCCCTCCCTECTCCCCCCTCTCT	NULL
CCCCACCCCTGGTGAAAACTGCGGEaTcqAtqGC	NULL
TGGGTGCAGCAACTGGAGGCGT	NULL
TGGCGCAC	NULL
TAGGAGGAGGC	NULL
TGCAG	NULL
A	NULL
AA	NULL
AD	NULL
AD	NULL
ACCACCCCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTGCTCCCCCCTCTCT	NULL
ﬂangnnnnanmqngnqnnnnmnﬁgnnnnqomnqnanWhPMWHmwgn82392332332326	NULL
CCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCCTCCCTECTCCCCCCTCTCT	NULL
CCCCACCCCTGGTGAAAACTGCGGGCTTCAGCGCTEGGTGCAGCAACTGGAGGCGTTGGCGCACTAGGAGGAGGCTGCAG	NULL
CTGAATCTAGAGTCCCTCCCTECTCCCCCCTCTCT	NULL
CCCCACCCCTGGTGAAAACTGCEGGCTTCAGCGCTGEGTGCAGCAACTGGAGGCGTTGGCGCAC	NULL
TAGGAGGAGGCTGCAG	NULL
CCCTCCCTECTCCCCCCTCTCTCCCCACCCCTGGTGAAAACTGCGGGCTTCAGCGCTGGGTGCAGCAACTGGAGGCGTTGGCGCACTAGGAGGAGGCTGCAG	NULL
CTCTCTCCCCACCCCTGGTGAAAACTGCGGGCTTCAGCGCTGGGTGCAGCAACTGGAGGCGTTGGCGCACTAGGAGGAGGC	NULL
TGCAG	NULL
GTGAAAACTGCGGGCTTCAGCGCTGGGTGCAGCAACTGGAGGCGTTGGCGCACTAGGAGGAGGCTGCAG	NULL
nan._.._	NULL
,	NULL
n	NULL
>	NULL
onnnqmnnqmn	NULL
>	NULL
nnW	NULL
>	NULL
nqngnmnnﬁnanngn432928233	NULL
ACCACCCCACCCCCTCCATCCTTTTCCCTCAGCCTCCGATTGGCTGAATCTAGAGTCCETCCCTGCTCCCCCCTCTCT	NULL
CCCCACCCC	NULL
TGGTGAAAACTECGG	NULL
GAGGCGTTGGCGCACTAGGAGGAGGCTGCAG	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
Thy-7	NULL
promoter	NULL
mutants	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
wild-type	NULL
mouse	NULL
Thy-7.2	NULL
gene	NULL
promoter	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
top	NULL
line	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
CD	NULL
mutants	NULL
are	NULL
designated	NULL
by	NULL
the	NULL
position	NULL
of	NULL
the	NULL
endpoint	NULL
of	NULL
the	NULL
5	NULL
'	NULL
deletion	NULL
.	NULL

The	NULL
LS	NULL
and	NULL
ID	NULL
mutants	NULL
are	NULL
designated	NULL
by	NULL
the	NULL
position	NULL
of	NULL
the	NULL
nucleotide	NULL
delimiting	NULL
the	NULL
and	NULL
3	NULL
'	NULL
endpoint	NULL
deletions	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
Thy-7.2	NULL
promoter	NULL
changed	NULL
by	NULL
the	NULL
C/al	NULL
linker	NULL
is	NULL
underlined	NULL
for	NULL
all	NULL
mutants	NULL
.	NULL

Nucleotides	NULL
altered	NULL
by	NULL
the	NULL
insertion	NULL
are	NULL
indicated	NULL
by	NULL
small	NULL
letters	NULL
.	NULL

Deletions	NULL
are	NULL
represented	NULL
by	NULL
bars	NULL
,	NULL
and	NULL
changes	NULL
in	NULL
the	NULL
spacing	NULL
of	NULL
the	NULL
insertions	NULL
are	NULL
shown	NULL
above	NULL
the	NULL
sequences	NULL
.	NULL

RA	NULL
values	NULL
represent	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
each	NULL
individual	NULL
mutant	NULL
relative	NULL
to	NULL
wild-type	NULL
activity	NULL
after	NULL
normalizing	NULL
for	NULL
the	NULL
cotransfected	NULL
B-globin	NULL
levels	NULL
.	NULL

The	NULL
mutants	NULL
were	NULL
tested	NULL
for	NULL
expression	NULL
efficiency	NULL
in	NULL
both	NULL
HeLa	NULL
and	NULL
L-cells	NULL
.	NULL

RA	NULL
data	NULL
are	NULL
mean	NULL
values	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
in	NULL
L	NULL
cells	NULL
and	NULL
at	NULL
least	NULL
four	NULL
different	NULL
experiments	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Closed	NULL
and	NULL
open	NULL
triangles	NULL
indicate	NULL
strong	NULL
and	NULL
weak	NULL
transcription	NULL
initiation	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

2220	NULL
SPANOPOULOU	NULL
ET	NULL
AL	NULL
.	NULL

u	NULL
1D-120	NULL
ID	NULL
-	NULL
67	NULL
4	NULL
1D-18	NULL
1D~52	NULL
«	NULL
-	NULL
«	NULL
-	NULL
»	NULL
d	NULL
BD	NULL
WT	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

1D-120	NULL
ID-67	NULL
D18	NULL
D	NULL
ID-41	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
by	NULL
S1	NULL
nuclease	NULL
protection	NULL
.	NULL

Mutants	NULL
were	NULL
cotransfected	NULL
in	NULL
HeLa	NULL
cells	NULL
with	NULL
a	NULL
human	NULL
B-globin	NULL
control	NULL
plasmid	NULL
and	NULL
expressed	NULL
transiently	NULL
for	NULL
48	NULL
h.	NULL
Total	NULL
mRNA	NULL
was	NULL
analyzed	NULL
by	NULL
S1	NULL
protection	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Total	NULL
RNA	NULL
(	NULL
30	NULL
ug	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
an	NULL
Xbal-Bgll	NULL
145-bp	NULL
probe	NULL
(	NULL
labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
)	NULL
which	NULL
detects	NULL
the	NULL
5'-end	NULL
termini	NULL
of	NULL
the	NULL
fusion	NULL
mRNAs	NULL
and	NULL
protects	NULL
84	NULL
to	NULL
90	NULL
bp	NULL
of	NULL
the	NULL
transcripts	NULL
.	NULL

The	NULL
position	NULL
of	NULL
wild-type	NULL
5	NULL
'	NULL
ends	NULL
is	NULL
indicated	NULL
by	NULL
arrows	NULL
;	NULL
novel	NULL
cap	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
dots	NULL
.	NULL

Of	NULL
the	NULL
larger	NULL
protected	NULL
bands	NULL
,	NULL
the	NULL
uppermost	NULL
band	NULL
represents	NULL
reannealed	NULL
probe	NULL
,	NULL
while	NULL
the	NULL
lower	NULL
bands	NULL
represent	NULL
upstream	NULL
transcripts	NULL
initiated	NULL
in	NULL
the	NULL
vector	NULL
.	NULL

Lane	NULL
M	NULL
,	NULL
marker	NULL
;	NULL
lane	NULL
C	NULL
,	NULL
negative	NULL
controls	NULL
for	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
ID	NULL
-18/+8	NULL
probes	NULL
,	NULL
representing	NULL
hybridization	NULL
to	NULL
30	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
nontransfected	NULL
HeLa	NULL
cells	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
hybrid	NULL
Thy-//y-globin	NULL
constructs	NULL
.	NULL

The	NULL
5'-end	NULL
S1	NULL
probe	NULL
(	NULL
Xbal	NULL
to	NULL
Bail	NULL
fragment	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

Restriction	NULL
sites	NULL
:	NULL
B	NULL
,	NULL
Bgill	NULL
;	NULL
S	NULL
,	NULL
Smal	NULL
;	NULL
X	NULL
,	NULL
Xbal	NULL
;	NULL
BI	NULL
,	NULL
Beil	NULL
;	NULL
H	NULL
,	NULL
HindlH	NULL
.	NULL

(	NULL
c	NULL
)	NULL
S1	NULL
analysis	NULL
of	NULL
human	NULL
-globin	NULL
mRNA	NULL
.	NULL

A	NULL
5'-end	NULL
probe	NULL
(	NULL
Accl-Accl	NULL
540-bp	NULL
fragment	NULL
which	NULL
protects	NULL
160	NULL
bp	NULL
)	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
the	NULL
transcripts	NULL
of	NULL
the	NULL
cotransfected	NULL
human	NULL
B-globin	NULL
plasmid	NULL
.	NULL

Thy-1	NULL
promoter	NULL
function	NULL
.	NULL

The	NULL
first	NULL
(	NULL
-91	NULL
to	NULL
-77	NULL
)	NULL
contains	NULL
an	NULL
inverted	NULL
CAAT	NULL
box	NULL
sequence	NULL
homologous	NULL
to	NULL
the	NULL
human	NULL
«	NULL
-globin	NULL
CCAAT	NULL
box	NULL
motif	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Regions	NULL
from	NULL
-68	NULL
to	NULL
-48	NULL
and	NULL
-41	NULL
to	NULL
-19	NULL
include	NULL
potential	NULL
Spl	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
third	NULL
region	NULL
is	NULL
defined	NULL
by	NULL
sequences	NULL
proximal	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
is	NULL
the	NULL
subject	NULL
of	NULL
a	NULL
separate	NULL
report	NULL
(	NULL
61b	NULL
)	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
protein	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
Thy-1	NULL
promoter	NULL
,	NULL
DNase	NULL
I	NULL
footprinting	NULL
and	NULL
gel	NULL
retardation	NULL
analyses	NULL
were	NULL
used	NULL
.	NULL

Binding	NULL
of	NULL
trans-acting	NULL
factors	NULL
to	NULL
the	NULL
minimal	NULL
region	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
,	NULL
DNase	NULL
I	NULL
footprinting	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
probe	NULL
that	NULL
contains	NULL
the	NULL
region	NULL
between	NULL
-270	NULL
and	NULL
+36	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
in	NULL
binding	NULL
reactions	NULL
with	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
mouse	NULL
brain	NULL
,	NULL
the	NULL
murine	NULL
T-cell	NULL
line	NULL
EL-4	NULL
,	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
human	NULL
erythroid	NULL
line	NULL
K562	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
the	NULL
presence	NULL
of	NULL
four	NULL
major	NULL
footprints	NULL
within	NULL
the	NULL
region	NULL
from	NULL
-100	NULL
to	NULL
+8	NULL
which	NULL
was	NULL
found	NULL
by	NULL
expression	NULL
analysis	NULL
to	NULL
be	NULL
sufficient	NULL
for	NULL
promoter	NULL
function	NULL
.	NULL

The	NULL
four	NULL
DNase	NULL
I-protected	NULL
areas	NULL
(	NULL
dashed	NULL
lines	NULL
in	NULL
Fig	NULL
.	NULL

5b	NULL
)	NULL
are	NULL
readily	NULL
detectable	NULL
on	NULL
both	NULL
DNA	NULL
strands	NULL
and	NULL
are	NULL
present	NULL
in	NULL
all	NULL
four	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Footprints	NULL
III	NULL
,	NULL
IV	NULL
,	NULL
and	NULL
V	NULL
overlap	NULL
with	NULL
regions	NULL
from	NULL
-91	NULL
to	NULL
-77	NULL
,	NULL
=-68	NULL
to	NULL
-48	NULL
,	NULL
and	NULL
-41	NULL
to	NULL
-19	NULL
,	NULL
respectively	NULL
,	NULL
which	NULL
were	NULL
found	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
incubation	NULL
with	NULL
different	NULL
extracts	NULL
produced	NULL
a	NULL
distinct	NULL
pattern	NULL
of	NULL
hypersensitive	NULL
sites	NULL
(	NULL
not	NULL
related	NULL
to	NULL
species	NULL
)	NULL
,	NULL
and	NULL
in	NULL
some	NULL
cases	NULL
the	NULL
borders	NULL
of	NULL
an	NULL
individual	NULL
protected	NULL
region	NULL
were	NULL
also	NULL
different	NULL
between	NULL
the	NULL
various	NULL
extracts	NULL
.	NULL

The	NULL
region	NULL
around	NULL
-25	NULL
to	NULL
-10	NULL
failed	NULL
to	NULL
show	NULL
any	NULL
obvious	NULL
protection	NULL
from	NULL
DNase	NULL
I	NULL
,	NULL
although	NULL
incubation	NULL
with	NULL
HeLa	NULL
extracts	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
strong	NULL
hypersensitive	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
one	NULL
extensive	NULL
,	NULL
weak	NULL
footprint	NULL
was	NULL
found	NULL
in	NULL
the	NULL
sequences	NULL
flanking	NULL
the	NULL
cap	NULL
site	NULL
,	NULL
which	NULL
we	NULL
have	NULL
arbitrarily	NULL
subdivided	NULL
into	NULL
three	NULL
regions	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
unprotected	NULL
nucleotides	NULL
(	NULL
regions	NULL
VI	NULL
,	NULL
VII	NULL
,	NULL
and	NULL
VIII	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
footprints	NULL
could	NULL
be	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
corresponding	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
)	NULL
in	NULL
all	NULL
four	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
protein	NULL
factors	NULL
by	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
individual	NULL
proteins	NULL
interacting	NULL
with	NULL
each	NULL
of	NULL
the	NULL
DNase	NULL
I-protected	NULL
regions	NULL
,	NULL
a	NULL
number	NULL
of	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
or	NULL
competitors	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
a	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Probe	NULL
THY-A	NULL
represents	NULL
the	NULL
regions	NULL
from	NULL
-115	NULL
to	NULL
-105	NULL
and	NULL
-41	NULL
to	NULL
-33	NULL
and	NULL
binds	NULL
four	NULL
distinct	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

Sa	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
first	NULL
two	NULL
slowly	NULL
migrating	NULL
complexes	NULL
were	NULL
also	NULL
detected	NULL
with	NULL
probes	NULL
THY-F	NULL
and	NULL
THY-G	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
with	NULL
THY-D	NULL
.	NULL

Since	NULL
the	NULL
common	NULL
motif	NULL
present	NULL
in	NULL
all	NULL
of	NULL
these	NULL
probes	NULL
was	NULL
reminiscent	NULL
of	NULL
the	NULL
Spl	NULL
binding	NULL
site	NULL
,	NULL
some	NULL
of	NULL
the	NULL
probes	NULL
were	NULL
tested	NULL
in	NULL
competition	NULL
experiments	NULL
with	NULL
a	NULL
genuine	NULL
GC	NULL
box	NULL
(	NULL
GC	NULL
boxes	NULL
III	NULL
and	NULL
IV	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
;	NULL
see	NULL
probe	NULL
Spl	NULL
GC	NULL
III	NULL
,	NULL
IV	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

THY-A	NULL
and	NULL
THY-F	NULL
bind	NULL
complexes	NULL
which	NULL
comi-grate	NULL
with	NULL
those	NULL
retarded	NULL
by	NULL
an	NULL
Spl	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

Sa	NULL
;	NULL
compare	NULL
lanes	NULL
21	NULL
,	NULL
23	NULL
,	NULL
and	NULL
25	NULL
)	NULL
.	NULL

These	NULL
complexes	NULL
are	NULL
competed	NULL
for	NULL
very	NULL
efficiently	NULL
by	NULL
the	NULL
Spl	NULL
probe	NULL
(	NULL
lanes	NULL
22	NULL
and	NULL
24	NULL
)	NULL
,	NULL
and	NULL
conversely	NULL
,	NULL
THY-A	NULL
and	NULL
F	NULL
compete	NULL
for	NULL
the	NULL
Spl	NULL
binding	NULL
Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
=	NULL
*	NULL
n	NULL
a	NULL
Ss	NULL
®	NULL
8	NULL
e	NULL
T	NULL
s	NULL
§	NULL
8	NULL
8	NULL
©	NULL
A	NULL
$	NULL
1	NULL
}	NULL
§	NULL
i	NULL
}	NULL
B.	NULL
i	NULL
$	NULL
g	NULL
;	NULL
i	NULL
$	NULL
s	NULL
w	NULL
m	NULL
e	NULL
x0	NULL
i	NULL
O	NULL
i	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Footprinting	NULL
analysis	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
.	NULL

A	NULL
5'-end-labeled	NULL
fragment	NULL
containing	NULL
the	NULL
promoter	NULL
region	NULL
between	NULL
-270	NULL
and	NULL
+36	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
binding	NULL
reactions	NULL
containing	NULL
50	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
,	NULL
mouse	NULL
brain	NULL
,	NULL
T	NULL
cells	NULL
(	NULL
cell	NULL
line	NULL
EL-4	NULL
)	NULL
,	NULL
and	NULL
the	NULL
erythroid	NULL
line	NULL
K562	NULL
.	NULL

Footprints	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
of	NULL
each	NULL
panel	NULL
;	NULL
hypersensitive	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
on	NULL
the	NULL
left	NULL
.	NULL

(	NULL
A	NULL
[	NULL
coding	NULL
strand	NULL
]	NULL
)	NULL
Two	NULL
different	NULL
lanes	NULL
of	NULL
DNA	NULL
without	NULL
extract	NULL
(	NULL
free	NULL
)	NULL
;	NULL
(	NULL
B	NULL
)	NULL
noncoding	NULL
strand	NULL
.	NULL

DETAILED	NULL
ANALYSIS	NULL
OF	NULL
THE	NULL
MURINE	NULL
Thy-/	NULL
GENE	NULL
PROMOTER	NULL
2221	NULL
pattern	NULL
(	NULL
lanes	NULL
27	NULL
and	NULL
28	NULL
)	NULL
.	NULL

The	NULL
THY-A	NULL
motif	NULL
CCCCACCCCC	NULL
represents	NULL
a	NULL
strong	NULL
Spl	NULL
binding	NULL
site	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
titration	NULL
competition	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
and	NULL
Fig	NULL
.	NULL

Sa	NULL
,	NULL
lanes	NULL
25	NULL
and	NULL
27	NULL
)	NULL
and	NULL
reported	NULL
by	NULL
Letovsky	NULL
and	NULL
Dynan	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
THY-F	NULL
CCCTCCC	NULL
motif	NULL
also	NULL
binds	NULL
Spl	NULL
but	NULL
with	NULL
a	NULL
lower	NULL
affinity	NULL
than	NULL
the	NULL
CCGCCC	NULL
or	NULL
the	NULL
CCCCACCCCC	NULL
motifs	NULL
and	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
promoter	NULL
,	NULL
where	NULL
it	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
purified	NULL
Spl	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Probe	NULL
THY-G	NULL
binds	NULL
Spl	NULL
by	NULL
the	NULL
CCCCACCC	NULL
motif	NULL
,	NULL
whereas	NULL
THY-D	NULL
has	NULL
a	NULL
weak	NULL
Spl	NULL
site	NULL
represented	NULL
by	NULL
the	NULL
CCTCC	NULL
sequences	NULL
.	NULL

Binding	NULL
of	NULL
Spl	NULL
to	NULL
these	NULL
motifs	NULL
was	NULL
also	NULL
tested	NULL
by	NULL
polyclonal	NULL
antibodies	NULL
raised	NULL
against	NULL
Spl	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
S.	NULL
Jackson	NULL
)	NULL
which	NULL
shift	NULL
the	NULL
upper	NULL
complex	NULL
formed	NULL
by	NULL
probes	NULL
THY-A	NULL
,	NULL
THY-F	NULL
,	NULL
THY-G	NULL
,	NULL
and	NULL
THY-D	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
complex	NULL
resolves	NULL
into	NULL
two	NULL
distinct	NULL
bands	NULL
which	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
Spl	NULL
forms	NULL
(	NULL
95	NULL
and	NULL
105	NULL
kDa	NULL
)	NULL
(	NULL
5	NULL
,	NULL
34	NULL
,	NULL
39	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
complex	NULL
is	NULL
designated	NULL
?	NULL

5pl	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
since	NULL
it	NULL
might	NULL
represent	NULL
a	NULL
degradation	NULL
or	NULL
posttranslational	NULL
product	NULL
of	NULL
Spl	NULL
(	NULL
14	NULL
,	NULL
27	NULL
,	NULL
46	NULL
)	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
this	NULL
complex	NULL
shows	NULL
binding	NULL
affinity	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
Spl	NULL
and	NULL
an	NULL
identical	NULL
competition	NULL
pattern	NULL
,	NULL
and	NULL
it	NULL
is	NULL
present	NULL
in	NULL
all	NULL
nuclear	NULL
extracts	NULL
tested	NULL
.	NULL

However	NULL
,	NULL
its	NULL
binding	NULL
remains	NULL
unaffected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
anti-Spl	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
(	NULL
which	NULL
,	NULL
however	NULL
,	NULL
do	NULL
not	NULL
recognize	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
the	NULL
protein	NULL
[	NULL
33a	NULL
]	NULL
)	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
by	NULL
others	NULL
that	NULL
it	NULL
represents	NULL
a	NULL
factor	NULL
distinct	NULL
from	NULL
Spl	NULL
(	NULL
71	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
factor	NULL
may	NULL
copurify	NULL
with	NULL
transcription	NULL
factor	NULL
LSF	NULL
(	NULL
30	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
possible	NULL
that	NULL
?	NULL

Spl	NULL
represents	NULL
a	NULL
factor	NULL
other	NULL
than	NULL
Spl	NULL
.	NULL

Methylation	NULL
interference	NULL
experiments	NULL
using	NULL
probes	NULL
THY-A	NULL
,	NULL
THY-F	NULL
,	NULL
and	NULL
Spl	NULL
GC	NULL
IIL	NULL
,	NULL
IV	NULL
show	NULL
that	NULL
methylation	NULL
of	NULL
most	NULL
of	NULL
the	NULL
available	NULL
G	NULL
residues	NULL
flanking	NULL
the	NULL
central	NULL
T	NULL
residue	NULL
prevents	NULL
the	NULL
binding	NULL
of	NULL
Spl	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

This	NULL
could	NULL
explain	NULL
the	NULL
high	NULL
binding	NULL
affinity	NULL
of	NULL
the	NULL
CCCCACCCCC	NULL
motif	NULL
.	NULL

Partial	NULL
proteolysis	NULL
of	NULL
complexes	NULL
formed	NULL
on	NULL
probes	NULL
THY-A	NULL
,	NULL
THY-F	NULL
,	NULL
and	NULL
Spl	NULL
GC	NULL
IIL	NULL
,	NULL
IV	NULL
also	NULL
indicated	NULL
that	NULL
the	NULL
upper	NULL
complex	NULL
is	NULL
indeed	NULL
Spl	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
mentioned	NULL
that	NULL
GC	NULL
box	NULL
IV	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
is	NULL
a	NULL
particularly	NULL
weak	NULL
Spl	NULL
binding	NULL
site	NULL
,	NULL
but	NULL
its	NULL
affinity	NULL
is	NULL
enhanced	NULL
by	NULL
mutations	NULL
in	NULL
GC	NULL
box	NULL
V	NULL
(	NULL
22	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
attribute	NULL
the	NULL
increased	NULL
interactions	NULL
between	NULL
Spl	NULL
and	NULL
GC	NULL
box	NULL
IV	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
GC	NULL
box	NULL
V.	NULL
Probe	NULL
THY-B	NULL
fails	NULL
to	NULL
bind	NULL
Spl	NULL
although	NULL
it	NULL
contains	NULL
a	NULL
candidate	NULL
Spl	NULL
binding	NULL
site	NULL
(	NULL
also	NULL
indicated	NULL
by	NULL
competition	NULL
assays	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
it	NULL
binds	NULL
a	NULL
novel	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

Sa	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
which	NULL
interacts	NULL
weakly	NULL
with	NULL
most	NULL
of	NULL
the	NULL
available	NULL
purines	NULL
present	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
panel	NULL
THY-B	NULL
)	NULL
.	NULL

Probe	NULL
THY-D	NULL
binds	NULL
a	NULL
factor	NULL
which	NULL
comigrates	NULL
with	NULL
the	NULL
complex	NULL
observed	NULL
on	NULL
probe	NULL
THY-B	NULL
.	NULL

However	NULL
,	NULL
competition	NULL
assays	NULL
between	NULL
probes	NULL
THY-B	NULL
and	NULL
THY-D	NULL
strongly	NULL
indicate	NULL
that	NULL
the	NULL
two	NULL
factors	NULL
are	NULL
different	NULL
.	NULL

This	NULL
is	NULL
verified	NULL
by	NULL
their	NULL
distinct	NULL
protection	NULL
patterns	NULL
obtained	NULL
by	NULL
methylation	NULL
interference	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
;	NULL
compare	NULL
panels	NULL
THY-D	NULL
and	NULL
THY-B	NULL
)	NULL
.	NULL

We	NULL
have	NULL
not	NULL
characterized	NULL
these	NULL
proteins	NULL
further	NULL
since	NULL
they	NULL
are	NULL
not	NULL
observed	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
see	NULL
below	NULL
)	NULL
and	NULL
deletion	NULL
of	NULL
these	NULL
sequences	NULL
only	NULL
has	NULL
a	NULL
marginal	NULL
effect	NULL
on	NULL
the	NULL
RA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
THY-B	NULL
binds	NULL
two	NULL
other	NULL
complexes	NULL
also	NULL
obtained	NULL
by	NULL
probes	NULL
THY-A	NULL
and	NULL
particularly	NULL
THY-G	NULL
.	NULL

These	NULL
two	NULL
factors	NULL
,	NULL
which	NULL
we	NULL
call	NULL
R1	NULL
and	NULL
R2	NULL
,	NULL
bind	NULL
with	NULL
different	NULL
affinities	NULL
to	NULL
most	NULL
of	NULL
the	NULL
Thy-/	NULL
probes	NULL
that	NULL
bind	NULL
Spl	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
15	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
may	NULL
be	NULL
degradation	NULL
products	NULL
of	NULL
Spl	NULL
.	NULL

However	NULL
,	NULL
R1	NULL
and	NULL
R2	NULL
do	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
GC	NULL
box	NULL
probe	NULL
,	NULL
nor	NULL
is	NULL
their	NULL
binding	NULL
to	NULL
probes	NULL
THY-A	NULL
and	NULL
THY-G	NULL
prevented	NULL
by	NULL
low	NULL
concentrations	NULL
of	NULL
GC	NULL
box	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Spl	NULL
polyclonal	NULL
antibodies	NULL
do	NULL
not	NULL
shift	NULL
complexes	NULL
R1	NULL
and	NULL
R2	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

SPANOPOULOU	NULL
ET	NULL
AL	NULL
.	NULL

2222	NULL
*saouanbas	NULL
Sutpuodsanoo	NULL
ay	NULL
;	NULL
aaoge	NULL
aur	NULL
snonumuoa	NULL
e	NULL
4q	NULL
pajeamput	NULL
st	NULL
saqord	NULL
uonepieia1	NULL
138	NULL
ay	NULL
:	NULL
yo	NULL
yoesa	NULL
Aq	NULL
possaod	NULL
uordar	NULL
auf	NULL
,	NULL
(	NULL
saum	NULL
paysep	NULL
)	NULL
saouanbas	NULL
ay	NULL
;	NULL
mojoq	NULL
pajuasaid	NULL
st	NULL
joenxa	NULL
fJoo-J	NULL
,	NULL
oy	NULL
}	NULL
;	NULL
ut	NULL
uonogsioid	NULL
1	NULL
aseng	NULL
4q	NULL
pauterqo	NULL
sjundj00	NULL
;	NULL
ay	NULL
)	NULL
;	NULL
o	NULL
y	NULL
'spuens	NULL
yNG	NULL
YJ0q	NULL
Jof	NULL
Qp+	NULL
pue	NULL
qZT-	NULL
soouanbas	NULL
7-44	NULL
;	NULL
(	NULL
q	NULL
)	NULL
'aue	NULL
;	NULL
yoes	NULL
aaoge	NULL
a	NULL
e	NULL
Aq	NULL
parouap	NULL
are	NULL
s1omaduoo	NULL
snoFojowop	NULL
ay	NULL
}	NULL
sajearput	NULL
aur	NULL
1amof	NULL
ay	NULL
}	NULL
'aqgoid	NULL
ay	NULL
)	NULL
sareatput	NULL
joued	NULL
yoreoa	NULL
anoge	NULL
aut	NULL
]	NULL
13ddn	NULL
34J	NULL
eToH	NULL
wor	NULL
;	NULL
joe1j	NULL
%	NULL
a	NULL
seajontu	NULL
Jo	NULL
Iv	NULL
)	NULL
zt	NULL
iim	NULL
'sajowoud	NULL
7-44	NULL
;	NULL
ay	NULL
;	NULL
Jo	NULL
sjuawaja	NULL
feuonaun	NULL
;	NULL
;	NULL
o	NULL
sAesse	NULL
jigs	NULL
Ayfigow	NULL
jan	NULL
(	NULL
2	NULL
)	NULL
°5	NULL
'Ol4	NULL
LITA	NULL
_~	NULL
>	NULL
IA	NULL
A	NULL
AT	NULL
IH	NULL
I	NULL
1	NULL
”	NULL
(	NULL
couch	NULL
a¢u	NULL
<	NULL
q	NULL
<	NULL
p	NULL
<	NULL
uoouaq	NULL
<	NULL
pquuo	NULL
<	NULL
aco	NULL
<	NULL
u_q_	NULL
<	NULL
u	NULL
<	NULL
__q	NULL
<	NULL
suu	NULL
<	NULL
<	NULL
_uuoqouu_u	NULL
<	NULL
aau	NULL
<	NULL
<	NULL
<	NULL
quu	NULL
<	NULL
_oquuuuo_wouu_wu_u	NULL
v199v391399v99v99v1	NULL
.	NULL

30393991	NULL
193999991	NULL
393993	NULL
Joqga_v	NULL
<	NULL
<	NULL
<	NULL
<	NULL
a	NULL
pq_gqqq	NULL
<	NULL
qquu_u_	NULL
1139999919913991	NULL
qu_w	NULL
<	NULL
u	NULL
<	NULL
_q_	NULL
<	NULL
<	NULL
opuqob_	NULL
<	NULL
sqq_qqc	NULL
<	NULL
q_qqH____uq_	NULL
<	NULL
uu_uguuu	NULL
<	NULL
uqqu	NULL
<	NULL
qqqs	NULL
1	NULL
,	NULL
Ab	NULL
A	NULL
ov	NULL
-	NULL
ol-of	NULL
t	NULL
=	NULL
,	NULL
ae	NULL
~~~	NULL
H-ABL	NULL
-	NULL
s	NULL
ssi	NULL
-	NULL
~-d-anL	NULL
C	NULL
V-	NULL
XnI	NULL
T-	NULL
AHI	NULL
ad	NULL
Y-	NULL
XHI	NULL
9-	NULL
KHL	NULL
J-	NULL
AHI	NULL
~	NULL
~-W-	NULL
AHL	NULL
3-AHL	NULL
--	NULL
'	NULL
a	NULL
6	NULL
Bc	NULL
it	NULL
92	NULL
Sz	NULL
ve	NULL
to	NULL
io	NULL
IZ	NULL
OG	NULL
61	NULL
81	NULL
2	NULL
9L	NULL
SL	NULL
PL	NULL
EL	NULL
Tl	NULL
LL	NULL
OL	NULL
6	NULL
8	NULL
L	NULL
9	NULL
S	NULL
b	NULL
og	NULL
[	NULL
4	NULL
L	NULL
-	NULL
wam	NULL
~	NULL
!	NULL

w	NULL
ind	NULL
par	NULL
A-	NULL
]	NULL
+-LH	NULL
dis	NULL
§	NULL
-=	NULL
«	NULL
n	NULL
Cul	NULL
wite	NULL
m	NULL
~-1dg	NULL
t	NULL
Wi	NULL
--	NULL
14s	NULL
b	NULL
C	NULL
t	NULL
$	NULL
A	NULL
tg	NULL
,	NULL
f	NULL
§	NULL
I	NULL
*~Ld	NULL
+149	NULL
--	NULL
1d9	NULL
1as	NULL
I	NULL
9	NULL
-	NULL
3	NULL
-	NULL
9	NULL
-	NULL
9	NULL
~	NULL
9	NULL
-	NULL
,	NULL
-	NULL
dwog	NULL
U	NULL
m	NULL
;	NULL
o	NULL
13	NULL
3	NULL
ire	NULL
#	NULL
_	NULL
_	NULL
3	NULL
U	NULL
|	NULL
&	NULL
A	NULL
|=	NULL
#	NULL
]	NULL
I	NULL
]	NULL
V-AHL	NULL
$	NULL
5..—	NULL
3-AHL	NULL
i	NULL
3-AHL	NULL
a-AHL	NULL
I-AHL	NULL
m-	NULL
>	NULL
:	NULL
»	NULL
_	NULL
W-XAHL	NULL
-	NULL
+29044	NULL
p	NULL
Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
prp	NULL
_	NULL
Spi	NULL
THY-G	NULL
CompD|-	NULL
-	NULL
_	NULL
}	NULL
5	NULL
)	NULL
!	NULL

s	NULL
=	NULL
_i	NULL
Sp1-Ab.D	NULL
¥	NULL
-	NULL
i	NULL
%	NULL
.	NULL

hte	NULL
cron	NULL
t	NULL
ss-Sp1-	NULL
wt	NULL
§p1=_	NULL
.	NULL

f	NULL
-=	NULL
be	NULL
@	NULL
.	NULL

.	NULL

»	NULL
n	NULL
”	NULL
3°1	NULL
”	NULL
..	NULL
#	NULL
#	NULL
._	NULL
o	NULL
R	NULL
»	NULL
‘	NULL
=R	NULL
“	NULL
7	NULL
es	NULL
iis	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Evidence	NULL
that	NULL
antibodies	NULL
against	NULL
transcription	NULL
factor	NULL
Spl	NULL
shift	NULL
the	NULL
Spl-formed	NULL
complex	NULL
but	NULL
do	NULL
not	NULL
alter	NULL
the	NULL
binding	NULL
pattern	NULL
of	NULL
factors	NULL
R1	NULL
and	NULL
R2	NULL
.	NULL

HeLa	NULL
Spl	NULL
binds	NULL
to	NULL
probe	NULL
Spl	NULL
(	NULL
GC	NULL
boxes	NULL
III	NULL
and	NULL
IV	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
)	NULL
and	NULL
produces	NULL
a	NULL
supershift	NULL
(	NULL
SS-Sp1	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
polyclonal	NULL
antibody	NULL
against	NULL
Spl	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
S.	NULL
Jackson	NULL
)	NULL
.	NULL

Probe	NULL
THY-G	NULL
produces	NULL
four	NULL
different	NULL
complexes	NULL
,	NULL
Sp1	NULL
,	NULL
R3	NULL
(	NULL
which	NULL
on	NULL
this	NULL
gel	NULL
comigrates	NULL
with	NULL
the	NULL
lower	NULL
Spl	NULL
form	NULL
)	NULL
,	NULL
R1	NULL
,	NULL
and	NULL
R2	NULL
.	NULL

Oligonucleotide	NULL
Spl	NULL
containing	NULL
GC	NULL
boxes	NULL
III	NULL
and	NULL
IV	NULL
efficiently	NULL
competes	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
Spl	NULL
but	NULL
not	NULL
of	NULL
R1	NULL
,	NULL
R2	NULL
,	NULL
and	NULL
R3	NULL
.	NULL

Anti-Sp1l	NULL
polyclonal	NULL
antibodies	NULL
shift	NULL
the	NULL
Spl-formed	NULL
complex	NULL
without	NULL
affecting	NULL
the	NULL
binding	NULL
patterns	NULL
of	NULL
R1	NULL
,	NULL
R2	NULL
,	NULL
and	NULL
R3	NULL
.	NULL

Spi-Ab	NULL
.	NULL

+	NULL
indicates	NULL
the	NULL
addition	NULL
of	NULL
antibody	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
;	NULL
Spl-Ab	NULL
.	NULL

indicates	NULL
the	NULL
addition	NULL
of	NULL
preimmune	NULL
serum	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
antibody	NULL
or	NULL
the	NULL
preimmune	NULL
serum	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
for	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

The	NULL
Spl	NULL
supershift	NULL
with	NULL
the	NULL
THY-G	NULL
probe	NULL
is	NULL
clearly	NULL
visible	NULL
on	NULL
higher	NULL
exposures	NULL
.	NULL

R2	NULL
homology	NULL
between	NULL
THY-A	NULL
,	NULL
THY-B	NULL
,	NULL
and	NULL
THY-G	NULL
indicates	NULL
that	NULL
R1	NULL
and	NULL
R2	NULL
might	NULL
require	NULL
a	NULL
minimum	NULL
of	NULL
five	NULL
G	NULL
residues	NULL
to	NULL
bind	NULL
efficiently	NULL
.	NULL

Indeed	NULL
,	NULL
methylation	NULL
interference	NULL
of	NULL
the	NULL
R1	NULL
and	NULL
R2	NULL
complexes	NULL
confirms	NULL
this	NULL
observation	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
panels	NULL
THY-B/R1	NULL
and	NULL
THY-G/R2	NULL
)	NULL
and	NULL
shows	NULL
that	NULL
R1	NULL
and	NULL
R2	NULL
bind	NULL
at	NULL
a	NULL
position	NULL
centered	NULL
around	NULL
-SO	NULL
to	NULL
-45	NULL
.	NULL

Probe	NULL
THY-G	NULL
binds	NULL
an	NULL
additional	NULL
factor	NULL
named	NULL
R3	NULL
(	NULL
Fig	NULL
.	NULL

Sa	NULL
,	NULL
lane	NULL
15	NULL
)	NULL
which	NULL
is	NULL
also	NULL
unaffected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
GC	NULL
box	NULL
competitor	NULL
probe	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
Spl	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
but	NULL
is	NULL
partially	NULL
competed	NULL
by	NULL
probes	NULL
THY-F	NULL
,	NULL
THY-A	NULL
,	NULL
and	NULL
THY-D	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Methylation	NULL
of	NULL
most	NULL
of	NULL
the	NULL
purine	NULL
residues	NULL
in	NULL
the	NULL
noncoding	NULL
strand	NULL
interferes	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
R3	NULL
to	NULL
probe	NULL
THY-G	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
panel	NULL
THY-G/R3	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
is	NULL
overlapping	NULL
but	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
R2	NULL
.	NULL

Finally	NULL
,	NULL
probe	NULL
THY-C	NULL
appears	NULL
to	NULL
bind	NULL
a	NULL
nonspecific	NULL
complex	NULL
.	NULL

The	NULL
other	NULL
functional	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
which	NULL
includes	NULL
an	NULL
inverted	NULL
CCAAT	NULL
box	NULL
,	NULL
was	NULL
tested	NULL
for	NULL
binding	NULL
activity	NULL
with	NULL
oligonucleotide	NULL
THY-E	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
binds	NULL
the	NULL
CCAAT-box-specific	NULL
transcription	NULL
factor	NULL
CPI	NULL
(	NULL
Fig	NULL
.	NULL

Sa	NULL
,	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
;	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
which	NULL
has	NULL
been	NULL
extensively	NULL
described	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
its	NULL
binding	NULL
pattern	NULL
is	NULL
not	NULL
competed	NULL
for	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-I	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Figure	NULL
8B	NULL
also	NULL
shows	NULL
the	NULL
binding	NULL
pattern	NULL
of	NULL
the	NULL
human	NULL
«	NULL
-globin	NULL
CCAAT	NULL
box	NULL
(	NULL
CPI1	NULL
activity	NULL
)	NULL
and	NULL
that	NULL
of	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
origin	NULL
of	NULL
replication	NULL
DETAILED	NULL
ANALYSIS	NULL
OF	NULL
THE	NULL
MURINE	NULL
Thy-/	NULL
GENE	NULL
PROMOTER	NULL
2223	NULL
(	NULL
NF-I	NULL
activity	NULL
)	NULL
in	NULL
all	NULL
four	NULL
nuclear	NULL
extracts	NULL
tested	NULL
.	NULL

Surprisingly	NULL
,	NULL
probe	NULL
THY-D	NULL
was	NULL
also	NULL
able	NULL
to	NULL
bind	NULL
CPI	NULL
although	NULL
with	NULL
a	NULL
lower	NULL
affinity	NULL
since	NULL
it	NULL
contains	NULL
part	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
but	NULL
carries	NULL
a	NULL
mutation	NULL
(	NULL
G	NULL
to	NULL
C	NULL
)	NULL
in	NULL
the	NULL
G	NULL
doublet	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
protein	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
results	NULL
obtained	NULL
from	NULL
the	NULL
binding	NULL
assays	NULL
and	NULL
the	NULL
expression	NULL
analyses	NULL
indicate	NULL
that	NULL
within	NULL
the	NULL
region	NULL
from	NULL
-100	NULL
to	NULL
-35	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
the	NULL
two	NULL
dominant	NULL
transcription	NULL
factors	NULL
are	NULL
Spl	NULL
and	NULL
CP1	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
sequences	NULL
centered	NULL
around	NULL
-80	NULL
(	NULL
CP1	NULL
)	NULL
and	NULL
-60	NULL
(	NULL
Sp1	NULL
)	NULL
.	NULL

Complex	NULL
formation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
brain	NULL
and	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
binding	NULL
pattern	NULL
of	NULL
Thy-1	NULL
probes	NULL
was	NULL
also	NULL
tested	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
brain	NULL
and	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

With	NULL
the	NULL
exception	NULL
of	NULL
THY-C	NULL
,	NULL
which	NULL
is	NULL
from	NULL
a	NULL
nonessential	NULL
part	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
all	NULL
oligonucleotides	NULL
exhibit	NULL
a	NULL
binding	NULL
pattern	NULL
resembling	NULL
the	NULL
one	NULL
obtained	NULL
with	NULL
HeLa	NULL
extracts	NULL
,	NULL
but	NULL
the	NULL
presence	NULL
of	NULL
factors	NULL
R1	NULL
and	NULL
R2	NULL
is	NULL
more	NULL
evident	NULL
in	NULL
the	NULL
T-cell	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Probe	NULL
THY-F	NULL
shows	NULL
enhanced	NULL
binding	NULL
of	NULL
a	NULL
factor	NULL
that	NULL
migrates	NULL
below	NULL
the	NULL
Spl	NULL
complex	NULL
and	NULL
is	NULL
more	NULL
prominent	NULL
in	NULL
T-cell	NULL
and	NULL
brain	NULL
nuclear	NULL
extracts	NULL
,	NULL
although	NULL
it	NULL
is	NULL
also	NULL
present	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
the	NULL
HeLa	NULL
extract	NULL
.	NULL

Probe	NULL
THY-G	NULL
selectively	NULL
binds	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
an	NULL
R2-like	NULL
complex	NULL
even	NULL
though	NULL
Spl	NULL
is	NULL
present	NULL
in	NULL
the	NULL
brain	NULL
extract	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
14	NULL
)	NULL
.	NULL

The	NULL
Thy-1	NULL
CCAAT	NULL
box	NULL
probe	NULL
(	NULL
THY-E	NULL
)	NULL
exhibits	NULL
a	NULL
binding	NULL
pattern	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
«	NULL
-globin	NULL
CCAAT	NULL
box	NULL
in	NULL
brain	NULL
and	NULL
thymus	NULL
extracts	NULL
,	NULL
and	NULL
this	NULL
pattern	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
NF-I	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
other	NULL
patterns	NULL
can	NULL
be	NULL
obtained	NULL
with	NULL
other	NULL
extracts	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
K562	NULL
;	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Specificity	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
used	NULL
transgenic	NULL
mice	NULL
as	NULL
an	NULL
in	NULL
vivo	NULL
expression	NULL
system	NULL
to	NULL
identify	NULL
a	NULL
number	NULL
of	NULL
tissue-specific	NULL
enhancer	NULL
elements	NULL
which	NULL
are	NULL
located	NULL
downstream	NULL
from	NULL
the	NULL
Thy-/	NULL
promoter	NULL
.	NULL

These	NULL
elements	NULL
also	NULL
function	NULL
when	NULL
the	NULL
Thy-/	NULL
promoter	NULL
is	NULL
replaced	NULL
by	NULL
heterologous	NULL
(	NULL
non-tissue-specific	NULL
)	NULL
promoters	NULL
(	NULL
67	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
did	NULL
not	NULL
exclude	NULL
that	NULL
the	NULL
Thy-/	NULL
promoter	NULL
itself	NULL
is	NULL
not	NULL
tissue	NULL
specific	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
in	NULL
this	NULL
study	NULL
by	NULL
using	NULL
the	NULL
Thy-//y-globin	NULL
transgene	NULL
clearly	NULL
show	NULL
that	NULL
the	NULL
Thy-/	NULL
promoter	NULL
fails	NULL
to	NULL
activate	NULL
initiation	NULL
of	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
enhancer	NULL
sequences	NULL
.	NULL

With	NULL
the	NULL
exception	NULL
of	NULL
transgenic	NULL
line	NULL
Tr.4	NULL
,	NULL
which	NULL
expresses	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
all	NULL
of	NULL
the	NULL
examined	NULL
tissues	NULL
,	NULL
the	NULL
hybrid	NULL
construct	NULL
remained	NULL
transcriptionally	NULL
silent	NULL
in	NULL
all	NULL
six	NULL
transgenic	NULL
lines	NULL
.	NULL

Some	NULL
transgenic	NULL
transcripts	NULL
were	NULL
present	NULL
in	NULL
the	NULL
brain	NULL
of	NULL
three	NULL
lines	NULL
at	NULL
levels	NULL
of	NULL
less	NULL
than	NULL
1	NULL
%	NULL
compared	NULL
with	NULL
the	NULL
endogenous	NULL
Thy-l	NULL
mRNA	NULL
.	NULL

Taking	NULL
into	NULL
account	NULL
the	NULL
high	NULL
copy	NULL
number	NULL
of	NULL
the	NULL
transgenes	NULL
,	NULL
the	NULL
expression	NULL
level	NULL
per	NULL
transgene	NULL
becomes	NULL
even	NULL
lower	NULL
.	NULL

The	NULL
brain-specific	NULL
transcripts	NULL
might	NULL
stem	NULL
from	NULL
the	NULL
diminished	NULL
expression	NULL
of	NULL
the	NULL
hybrid	NULL
gene	NULL
in	NULL
the	NULL
different	NULL
neuronal	NULL
subtypes	NULL
expressing	NULL
Thy-l	NULL
or	NULL
the	NULL
specific	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
a	NULL
particular	NULL
subtype	NULL
of	NULL
neuronal	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
they	NULL
might	NULL
represent	NULL
aberrant	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
nonneuronal	NULL
cells	NULL
because	NULL
they	NULL
do	NULL
not	NULL
show	NULL
the	NULL
pattern	NULL
of	NULL
initiation	NULL
typical	NULL
for	NULL
the	NULL
brain	NULL
(	NULL
62	NULL
)	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
to	NULL
initiate	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
enhancer	NULL
sequences	NULL
agrees	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
from	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
lines	NULL
(	NULL
23	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Clearly	NULL
no	NULL
specificity	NULL
is	NULL
conferred	NULL
by	NULL
the	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
Thy-/	NULL
is	NULL
one	NULL
of	NULL
the	NULL
few	NULL
genes	NULL
(	NULL
3	NULL
,	NULL
9	NULL
,	NULL
20	NULL
)	NULL
with	NULL
tissue-specific	NULL
control	NULL
elements	NULL
only	NULL
located	NULL
downstream	NULL
of	NULL
promoter	NULL
elements	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
number	NULL
of	NULL
tissue-specific	NULL
genes	NULL
contain	NULL
promoters	NULL
with	NULL
housekeeping	NULL
characteristics	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
19	NULL
)	NULL
,	NULL
but	NULL
unlike	NULL
2224	NULL
SPANOPOULOU	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
.	NULL

C	NULL
___	NULL
F	NULL
.B	NULL
F	NULL
B	NULL
F	NULL
8	NULL
``	NULL
``	NULL
T	NULL
T	NULL
¢	NULL
R	NULL
3	NULL
+G	NULL
c	NULL
8	NULL
I	NULL
A	NULL
e	NULL
'	NULL
a	NULL
a	NULL
.	NULL

W	NULL
a	NULL
M	NULL
I	NULL
R	NULL
c	NULL
Wy	NULL
¢	NULL
$	NULL
C	NULL
c	NULL
M	NULL
C	NULL
c	NULL
R	NULL
__	NULL
1	NULL
did	NULL
c	NULL
A	NULL
c	NULL
>	NULL
G	NULL
A-	NULL
wits	NULL
A	NULL
+6	NULL
A	NULL
¢	NULL
w	NULL
a	NULL
-c	NULL
-	NULL
(	NULL
#	NULL
c	NULL
A	NULL
c	NULL
A	NULL
&	NULL
c	NULL
C	NULL
n-cd	NULL
cd	NULL
“	NULL
cg	NULL
B.	NULL
THY-D	NULL
,	NULL
THY-B	NULL
_THY-B_	NULL
B	NULL
F	NULL
F	NULL
B	NULL
B	NULL
F	NULL
F	NULL
B	NULL
6	NULL
F	NULL
F	NULL
B	NULL
‘	NULL
\	NULL
p	NULL
«	NULL
TB	NULL
c	NULL
”	NULL
ﬂ	NULL
C	NULL
caren	NULL
C	NULL
_	NULL
»	NULL
G	NULL
c	NULL
6	NULL
A	NULL
»	NULL
6	NULL
A	NULL
6	NULL
C	NULL
»	NULL
G	NULL
a	NULL
G	NULL
¢	NULL
-	NULL
Wealh	NULL
I	NULL
4	NULL
A	NULL
c	NULL
6	NULL
6	NULL
G	NULL
m	NULL
T	NULL
f	NULL
ane	NULL
c	NULL
vi	NULL
.	NULL

I	NULL
geage	NULL
&	NULL
a	NULL
r	NULL
ha	NULL
,	NULL
®	NULL
G	NULL
6	NULL
<	NULL
i	NULL
A	NULL
h	NULL
C	NULL
T	NULL
¢	NULL
A	NULL
a	NULL
c	NULL
F	NULL
_	NULL
...	NULL
...	NULL
c	NULL
a	NULL
A	NULL
T	NULL
G	NULL
T	NULL
»	NULL
G	NULL
came	NULL
8	NULL
p	NULL
6	NULL
C	NULL
6	NULL
¢	NULL
C	NULL
;	NULL
c	NULL
c	NULL
$	NULL
A	NULL
<	NULL
ma	NULL
c	NULL
y	NULL
C	NULL
;	NULL
A	NULL
\	NULL
C	NULL
1	NULL
c	NULL
A	NULL
a	NULL
F	NULL
:	NULL
c	NULL
F	NULL
.	NULL

n-ed	NULL
.	NULL

cd	NULL
n-cd	NULL
cd	NULL
n-ed	NULL
cd	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

___	NULL
GCIILV	NULL
F	NULL
oB	NULL
FOB	NULL
Fo	NULL
B	NULL
§	NULL
<	NULL
-	NULL
W	NULL
._	NULL
im	NULL
»	NULL
w	NULL
as	NULL
**	NULL
§	NULL
'	NULL
¢	NULL
»	NULL
6	NULL
:	NULL
B	NULL
|	NULL
#	NULL
3	NULL
7	NULL
A	NULL
i	NULL
C	NULL
1	NULL
c	NULL
wo	NULL
@	NULL
t	NULL
@	NULL
R	NULL
c	NULL
we	NULL
**	NULL
{	NULL
j	NULL
‘	NULL
c	NULL
c	NULL
$	NULL
+G	NULL
.	NULL

#	NULL
#	NULL
a	NULL
-	NULL
<	NULL
UP	NULL
A	NULL
®	NULL
G	NULL
P	NULL
7	NULL
d	NULL
IX	NULL
-E	NULL
T	NULL
A	NULL
A	NULL
A	NULL
A	NULL
c	NULL
C	NULL
G	NULL
G	NULL
A	NULL
A	NULL
wis	NULL
a	NULL
G	NULL
#	NULL
a	NULL
c	NULL
is	NULL
W	NULL
A	NULL
>	NULL
G	NULL
a	NULL
c	NULL
»	NULL
G	NULL
‘	NULL
L	NULL
>	NULL
G	NULL
ane	NULL
c	NULL
»	NULL
o	NULL
Wen	NULL
C	NULL
>	NULL
G	NULL
i	NULL
t	NULL
»	NULL
G	NULL
aas	NULL
>	NULL
G	NULL
«	NULL
im	NULL
A	NULL
6	NULL
A	NULL
G	NULL
£	NULL
§	NULL
A	NULL
c	NULL
A	NULL
6	NULL
7	NULL
e	NULL
i	NULL
A	NULL
A	NULL
G	NULL
c	NULL
6	NULL
g	NULL
c	NULL
»	NULL
G	NULL
:	NULL
T	NULL
»	NULL
G	NULL
6	NULL
C	NULL
»	NULL
G	NULL
I	NULL
c	NULL
T	NULL
is	NULL
L	NULL
F	NULL
6	NULL
c	NULL
``	NULL
C	NULL
I	NULL
j	NULL
6	NULL
&	NULL
G	NULL
g	NULL
nle	NULL
#	NULL
a	NULL
n-cd	NULL
cd	NULL
n-cd	NULL
cd	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Methylation	NULL
interference	NULL
patterns	NULL
of	NULL
transcription	NULL
factor	NULL
Spl	NULL
.	NULL

The	NULL
coding	NULL
(	NULL
cd	NULL
)	NULL
and	NULL
noncoding	NULL
(	NULL
n-cd	NULL
)	NULL
strands	NULL
of	NULL
oligonucleotides	NULL
THY-A	NULL
,	NULL
THY-F	NULL
,	NULL
and	NULL
the	NULL
early	NULL
(	NULL
E	NULL
)	NULL
and	NULL
late	NULL
(	NULL
L	NULL
)	NULL
strands	NULL
of	NULL
GC	NULL
boxes	NULL
III	NULL
and	NULL
IV	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
region	NULL
,	NULL
were	NULL
partially	NULL
methylated	NULL
(	NULL
48	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
gel	NULL
retardation	NULL
binding	NULL
reactions	NULL
were	NULL
scaled	NULL
up	NULL
10-fold	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
excised	NULL
bands	NULL
by	NULL
electroelution	NULL
and	NULL
subjected	NULL
to	NULL
sodium	NULL
hydroxide-sodium	NULL
phosphate	NULL
treatment	NULL
to	NULL
cleave	NULL
the	NULL
methylated	NULL
purine	NULL
residues	NULL
.	NULL

Free	NULL
(	NULL
F	NULL
)	NULL
and	NULL
complexed	NULL
(	NULL
B	NULL
)	NULL
DNA	NULL
is	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

Open	NULL
and	NULL
filled	NULL
triangles	NULL
indicate	NULL
weak	NULL
and	NULL
strong	NULL
interference	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Methylation	NULL
interference	NULL
patterns	NULL
of	NULL
the	NULL
abundant	NULL
complexes	NULL
bound	NULL
to	NULL
probes	NULL
THY-D	NULL
and	NULL
THY-B	NULL
and	NULL
of	NULL
factors	NULL
R1	NULL
,	NULL
R2	NULL
,	NULL
and	NULL
R3	NULL
.	NULL

Factor	NULL
R1	NULL
is	NULL
complexed	NULL
with	NULL
probe	NULL
THY-B	NULL
(	NULL
since	NULL
it	NULL
exhibits	NULL
the	NULL
highest	NULL
affinity	NULL
)	NULL
,	NULL
whereas	NULL
factors	NULL
R3	NULL
and	NULL
R2	NULL
are	NULL
detected	NULL
by	NULL
the	NULL
same	NULL
probe	NULL
(	NULL
THY-G	NULL
)	NULL
.	NULL

Thy-1	NULL
,	NULL
they	NULL
exhibit	NULL
transcriptional	NULL
promiscuity	NULL
in	NULL
a	NULL
diverse	NULL
number	NULL
of	NULL
heterologous	NULL
cells	NULL
after	NULL
gene	NULL
transfer	NULL
(	NULL
60	NULL
,	NULL
69	NULL
)	NULL
.	NULL

Distal	NULL
domains	NULL
required	NULL
for	NULL
promoter	NULL
function	NULL
.	NULL

(	NULL
i	NULL
)	NULL
The	NULL
CCAAT	NULL
box	NULL
region	NULL
.	NULL

The	NULL
first	NULL
element	NULL
essential	NULL
for	NULL
promoter	NULL
function	NULL
maps	NULL
in	NULL
the	NULL
region	NULL
containing	NULL
an	NULL
inverted	NULL
CCAAT	NULL
box	NULL
.	NULL

The	NULL
corresponding	NULL
Thy-1	NULL
CCAAT	NULL
probe	NULL
reveals	NULL
a	NULL
certain	NULL
heterogeneity	NULL
when	NULL
analyzed	NULL
by	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

The	NULL
probe	NULL
mainly	NULL
detects	NULL
CPI	NULL
activity	NULL
in	NULL
all	NULL
four	NULL
extracts	NULL
tested	NULL
.	NULL

However	NULL
,	NULL
it	NULL
also	NULL
binds	NULL
to	NULL
a	NULL
faster-migrating	NULL
complex	NULL
that	NULL
is	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
NF-I	NULL
probe	NULL
.	NULL

An	NULL
additional	NULL
minor	NULL
activity	NULL
unique	NULL
to	NULL
the	NULL
Thy-/	NULL
probe	NULL
is	NULL
observed	NULL
in	NULL
the	NULL
T-cell	NULL
extracts	NULL
.	NULL

It	NULL
is	NULL
now	NULL
well	NULL
established	NULL
that	NULL
distinct	NULL
CCAAT-binding	NULL
proteins	NULL
with	NULL
variable	NULL
binding	NULL
affinities	NULL
exist	NULL
within	NULL
a	NULL
cell	NULL
(	NULL
8	NULL
,	NULL
17	NULL
,	NULL
25	NULL
,	NULL
35	NULL
,	NULL
36	NULL
,	NULL
59	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
,	NULL
the	NULL
major	NULL
CCAAT-binding	NULL
activity	NULL
is	NULL
contributed	NULL
by	NULL
CP1	NULL
,	NULL
which	NULL
therefore	NULL
is	NULL
the	NULL
primary	NULL
candidate	NULL
for	NULL
participating	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
The	NULL
region	NULL
from	NULL
-68	NULL
to	NULL
-31	NULL
and	NULL
binding	NULL
of	NULL
several	NULL
proteins	NULL
to	NULL
GC-rich	NULL
motifs	NULL
.	NULL

The	NULL
functional	NULL
importance	NULL
of	NULL
this	NULL
region	NULL
is	NULL
demonstrated	NULL
by	NULL
a	NULL
number	NULL
of	NULL
promoter	NULL
mutations	NULL
.	NULL

Substitution	NULL
of	NULL
the	NULL
CCCTCCC	NULL
motif	NULL
(	NULL
-63	NULL
to	NULL
-57	NULL
)	NULL
by	NULL
linker	NULL
sequences	NULL
has	NULL
a	NULL
detrimental	NULL
effect	NULL
on	NULL
promoter	NULL
efficiency	NULL
.	NULL

This	NULL
motif	NULL
binds	NULL
transcription	NULL
factor	NULL
Spl	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
the	NULL
competition	NULL
assays	NULL
and	NULL
shown	NULL
by	NULL
antibody	NULL
experiments	NULL
.	NULL

Spl	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
CCCCACCCC	NULL
motif	NULL
(	NULL
-4l1	NULL
to	NULL
-33	NULL
)	NULL
which	NULL
constitutes	NULL
the	NULL
other	NULL
important	NULL
element	NULL
for	NULL
promoter	NULL
function	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
Spl	NULL
binding	NULL
activity	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
in	NULL
vivo	NULL
activation	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
,	NULL
whereas	NULL
the	NULL
data	NULL
from	NULL
transgenic	NULL
mice	NULL
indicate	NULL
that	NULL
Spl	NULL
Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
DETAILED	NULL
ANALYSIS	NULL
OF	NULL
THE	NULL
MURINE	NULL
Thy-/	NULL
GENE	NULL
PROMOTER	NULL
2225	NULL
A.	NULL
Prober	NULL
THY-A	NULL
THY-B	NULL
THY-C	NULL
THY-D	NULL
THY-F	NULL
THY-G	NULL
GCil	NULL
Tissuer	NULL
'	NULL
t	NULL
B	NULL
'	NULL
``	NULL
t	NULL
8	NULL
tos	NULL
to	NULL
B	NULL
``	NULL
ToB	NULL
Ac-B	NULL
$	NULL
%	NULL
``	NULL
--	NULL
CG	NULL
Sp1-	NULL
Sp1-	NULL
g	NULL
|	NULL
si-	NULL
Spt-f	NULL
cpr-	NULL
&	NULL
s-	NULL
Ww	NULL
``	NULL
~	NULL
G2	NULL
-	NULL
r	NULL
R-	NULL
A1-	NULL
.	NULL

®	NULL
At-	NULL
Q	NULL
m-£25	NULL
.	NULL

wa	NULL
.	NULL

R2-	NULL
R2-	NULL
'	NULL
_	NULL
mwa	NULL
--	NULL
M	NULL
a	NULL
N	NULL
a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
B.	NULL
Prober	NULL
THY-E	NULL
CPi	NULL
NF	NULL
|	NULL
cia	NULL
FEE	NULL
,	NULL
n	NULL
amar	NULL
ina	NULL
are	NULL
I	NULL
|S	NULL
]	NULL
|	NULL
€	NULL
Competitor	NULL
-	NULL
E	NULL
8	NULL
£	NULL
-	NULL
E	NULL
$	NULL
%	NULL
.	NULL

R	NULL
B	NULL
&	NULL
-	NULL
.	NULL

-	NULL
soe	NULL
z	NULL
ME	NULL
g	NULL
+	NULL
CP1+	NULL
»	NULL
B	NULL
me	NULL
cri+	NULL
T	NULL
&	NULL
#	NULL
i_	NULL
aweig	NULL
acc	NULL
@	NULL
pmtancces	NULL
?	NULL

*	NULL
``	NULL
4	NULL
*all	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
Extract	NULL
>	NULL
|_	NULL
T-cell	NULL
J|	NULL
HeLa	NULL
J|	NULL
K562	NULL
|T	NULL
H	NULL
K	NULL
T	NULL
H	NULL
K	NULL
|__Brain	NULL
_|	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Complex	NULL
formation	NULL
on	NULL
oligonucleotides	NULL
THY-A	NULL
to	NULL
THY-G	NULL
and	NULL
the	NULL
Sp1	NULL
GC	NULL
III	NULL
,	NULL
IV	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
brain	NULL
or	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Oligonucleotides	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
were	NULL
tested	NULL
for	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
12	NULL
ug	NULL
of	NULL
whole	NULL
mouse	NULL
brain	NULL
(	NULL
B	NULL
)	NULL
or	NULL
T-cell	NULL
(	NULL
EL-4	NULL
line	NULL
)	NULL
(	NULL
T	NULL
)	NULL
nuclear	NULL
extracts	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
binding	NULL
pattern	NULL
of	NULL
the	NULL
Thy-/	NULL
probe	NULL
,	NULL
THY-E	NULL
,	NULL
containing	NULL
the	NULL
CAAT	NULL
box	NULL
motif	NULL
is	NULL
shown	NULL
in	NULL
reactions	NULL
containing	NULL
12	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
cell	NULL
lines	NULL
HeLa	NULL
,	NULL
EL-4	NULL
(	NULL
T	NULL
cell	NULL
)	NULL
,	NULL
and	NULL
K562	NULL
as	NULL
well	NULL
as	NULL
from	NULL
mouse	NULL
brain	NULL
.	NULL

The	NULL
binding	NULL
pattern	NULL
is	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
«	NULL
-globin	NULL
CAAT	NULL
box	NULL
motif	NULL
(	NULL
CP1	NULL
)	NULL
and	NULL
the	NULL
NF-I	NULL
binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
adenovirus	NULL
origin	NULL
of	NULL
replication	NULL
.	NULL

(	NULL
and/or	NULL
CP1	NULL
)	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
expression	NULL
.	NULL

The	NULL
binding	NULL
assays	NULL
revealed	NULL
the	NULL
abundant	NULL
presence	NULL
of	NULL
Spl	NULL
not	NULL
only	NULL
in	NULL
HeLa	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
K562	NULL
,	NULL
murine	NULL
brain	NULL
,	NULL
and	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Transcription	NULL
factor	NULL
Spl	NULL
is	NULL
found	NULL
in	NULL
two	NULL
forms	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
glycosylated	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
and	NULL
transcription	NULL
activation	NULL
domains	NULL
of	NULL
the	NULL
protein	NULL
have	NULL
been	NULL
extensively	NULL
characterized	NULL
(	NULL
11	NULL
,	NULL
39	NULL
,	NULL
40	NULL
)	NULL
;	NULL
Spl	NULL
interacts	NULL
with	NULL
(	NULL
possibly	NULL
)	NULL
only	NULL
one	NULL
of	NULL
the	NULL
two	NULL
DNA	NULL
strands	NULL
(	NULL
21	NULL
)	NULL
and	NULL
activates	NULL
transcription	NULL
in	NULL
a	NULL
bidirectional	NULL
manner	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Activation	NULL
can	NULL
occur	NULL
from	NULL
either	NULL
distal	NULL
or	NULL
proximal	NULL
elements	NULL
and	NULL
in	NULL
a	NULL
synergistic	NULL
way	NULL
(	NULL
10	NULL
)	NULL
.	NULL

These	NULL
properties	NULL
of	NULL
the	NULL
protein	NULL
are	NULL
particularly	NULL
interesting	NULL
in	NULL
the	NULL
context	NULL
of	NULL
potential	NULL
interactions	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
Spl	NULL
mediates	NULL
its	NULL
effect	NULL
directly	NULL
or	NULL
through	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

The	NULL
region	NULL
from	NULL
-57	NULL
to	NULL
-33	NULL
binds	NULL
three	NULL
proteins	NULL
,	NULL
termed	NULL
R1	NULL
,	NULL
R2	NULL
,	NULL
and	NULL
R3	NULL
,	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
distinct	NULL
from	NULL
Spl	NULL
by	NULL
a	NULL
number	NULL
of	NULL
criteria	NULL
.	NULL

They	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
probe	NULL
THY-G	NULL
but	NULL
not	NULL
to	NULL
the	NULL
Spl	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
to	NULL
7	NULL
)	NULL
.	NULL

Probe	NULL
THY-B	NULL
preferentially	NULL
binds	NULL
R1	NULL
,	NULL
whereas	NULL
probe	NULL
THY-A	NULL
binds	NULL
R1	NULL
and	NULL
R2	NULL
with	NULL
low	NULL
affinities	NULL
.	NULL

R1	NULL
and	NULL
R2	NULL
activities	NULL
are	NULL
more	NULL
abundant	NULL
in	NULL
the	NULL
T-cell	NULL
extract	NULL
than	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
homology	NULL
between	NULL
the	NULL
probes	NULL
predicts	NULL
that	NULL
factors	NULL
R1	NULL
and	NULL
R2	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
five	NULL
G	NULL
residues	NULL
to	NULL
bind	NULL
efficiently	NULL
.	NULL

This	NULL
view	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
methylation	NULL
interference	NULL
data	NULL
which	NULL
show	NULL
that	NULL
R1	NULL
and	NULL
R2	NULL
bind	NULL
to	NULL
five	NULL
adjacent	NULL
G	NULL
residues	NULL
,	NULL
whereas	NULL
factor	NULL
R3	NULL
interacts	NULL
weakly	NULL
with	NULL
all	NULL
purines	NULL
available	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Lastly	NULL
,	NULL
Spl	NULL
antibodies	NULL
only	NULL
interfere	NULL
with	NULL
Spl	NULL
binding	NULL
.	NULL

An	NULL
increasing	NULL
number	NULL
of	NULL
nuclear	NULL
proteins	NULL
,	NULL
exhibiting	NULL
activator	NULL
or	NULL
repressor	NULL
function	NULL
,	NULL
have	NULL
been	NULL
found	NULL
to	NULL
interact	NULL
with	NULL
GC-rich	NULL
motifs	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
32	NULL
,	NULL
42	NULL
,	NULL
43	NULL
,	NULL
52	NULL
,	NULL
53	NULL
,	NULL
68	NULL
)	NULL
.	NULL

The	NULL
most	NULL
striking	NULL
example	NULL
of	NULL
these	NULL
is	NULL
factor	NULL
LSF	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
two	NULL
adjacent	NULL
Spl	NULL
binding	NULL
sites	NULL
positioned	NULL
10	NULL
bp	NULL
apart	NULL
(	NULL
30	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
what	NULL
the	NULL
nature	NULL
of	NULL
factors	NULL
R1	NULL
,	NULL
R2	NULL
,	NULL
and	NULL
R3	NULL
is	NULL
,	NULL
but	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
methylation	NULL
interference	NULL
data	NULL
we	NULL
can	NULL
not	NULL
correlate	NULL
them	NULL
to	NULL
any	NULL
other	NULL
reported	NULL
factors	NULL
.	NULL

Surprisingly	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
an	NULL
activity	NULL
equivalent	NULL
to	NULL
the	NULL
HeLa	NULL
factor	NULL
H4TF1	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
sequence	NULL
5'-GGGGGAGGG-3	NULL
'	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Our	NULL
methylation	NULL
interference	NULL
data	NULL
on	NULL
probe	NULL
THY-A	NULL
clearly	NULL
indicate	NULL
that	NULL
the	NULL
2226	NULL
SPANOPOULOU	NULL
ET	NULL
AL	NULL
.	NULL

-80	NULL
-60	NULL
~40	NULL
-20	NULL
+1	NULL
basic	NULL
initiation	NULL
factors	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
nuclear	NULL
factors	NULL
bound	NULL
to	NULL
the	NULL
minimal	NULL
region	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
binding	NULL
studies	NULL
.	NULL

The	NULL
Spl	NULL
site	NULL
at	NULL
-60	NULL
and	NULL
the	NULL
CPI	NULL
site	NULL
at	NULL
-80	NULL
appear	NULL
to	NULL
be	NULL
indispensable	NULL
for	NULL
promoter	NULL
activity	NULL
.	NULL

Elimination	NULL
of	NULL
the	NULL
Spl	NULL
site	NULL
at	NULL
-40	NULL
decreases	NULL
promoter	NULL
activity	NULL
by	NULL
55	NULL
%	NULL
.	NULL

Factors	NULL
Spl	NULL
at	NULL
-120	NULL
and	NULL
factors	NULL
R1	NULL
and	NULL
R2	NULL
at	NULL
-50	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
promoter	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

bound	NULL
complex	NULL
interacts	NULL
with	NULL
most	NULL
of	NULL
the	NULL
guanosine	NULL
residues	NULL
available	NULL
,	NULL
a	NULL
pattern	NULL
almost	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
H4TFI	NULL
.	NULL

By	NULL
performing	NULL
partial	NULL
proteolysis	NULL
experiments	NULL
and	NULL
using	NULL
Spl	NULL
antibodies	NULL
in	NULL
supershift	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
bound	NULL
complex	NULL
clearly	NULL
represents	NULL
Spl	NULL
.	NULL

We	NULL
therefore	NULL
believe	NULL
that	NULL
the	NULL
5-GGGGGAGGG-3	NULL
'	NULL
sequence	NULL
binds	NULL
Spl	NULL
with	NULL
an	NULL
affinity	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
fragment	NULL
(	NULL
also	NULL
indicated	NULL
by	NULL
competition	NULL
assays	NULL
with	NULL
probes	NULL
THY-A	NULL
and	NULL
Spl	NULL
GC	NULL
III	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
efficiency	NULL
of	NULL
promoter	NULL
mutants	NULL
within	NULL
the	NULL
region	NULL
from	NULL
-68	NULL
to	NULL
-31	NULL
indicates	NULL
that	NULL
it	NULL
is	NULL
Spl	NULL
rather	NULL
than	NULL
R1	NULL
,	NULL
R2	NULL
,	NULL
or	NULL
R3	NULL
that	NULL
is	NULL
required	NULL
for	NULL
promoter	NULL
function	NULL
,	NULL
although	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
R1	NULL
,	NULL
R2	NULL
,	NULL
and	NULL
R3	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
in	NULL
a	NULL
different	NULL
cell	NULL
type	NULL
.	NULL

The	NULL
functional	NULL
importance	NULL
of	NULL
sequences	NULL
flanking	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

A	NULL
major	NULL
feature	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
is	NULL
the	NULL
utilization	NULL
of	NULL
multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
,	NULL
which	NULL
is	NULL
possibly	NULL
related	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
classical	NULL
TATA	NULL
motif	NULL
(	NULL
23	NULL
,	NULL
62	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
TATA	NULL
box	NULL
region	NULL
is	NULL
substituted	NULL
by	NULL
the	NULL
sequence	NULL
AAAA	NULL
,	NULL
which	NULL
represents	NULL
a	NULL
weak	NULL
TATA	NULL
motif	NULL
.	NULL

The	NULL
expression	NULL
analysis	NULL
of	NULL
mutations	NULL
LS	NULL
-24/~-19	NULL
and	NULL
-18/-10	NULL
and	NULL
ID	NULL
-18/+8	NULL
clearly	NULL
shows	NULL
that	NULL
sequences	NULL
flanking	NULL
the	NULL
cap	NULL
site	NULL
are	NULL
essential	NULL
for	NULL
promoter	NULL
function	NULL
,	NULL
whereas	NULL
mutations	NULL
in	NULL
the	NULL
cap	NULL
site	NULL
region	NULL
(	NULL
LS	NULL
-1/+8	NULL
)	NULL
result	NULL
in	NULL
a	NULL
55	NULL
%	NULL
decrease	NULL
in	NULL
transcription	NULL
efficiency	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
S1	NULL
analysis	NULL
of	NULL
the	NULL
exogenous	NULL
transcripts	NULL
revealed	NULL
that	NULL
all	NULL
mutations	NULL
located	NULL
around	NULL
the	NULL
principal	NULL
start	NULL
site	NULL
(	NULL
LS	NULL
-24/19	NULL
,	NULL
LS	NULL
-18/-10	NULL
,	NULL
and	NULL
LS	NULL
-1/+8	NULL
)	NULL
produce	NULL
mRNAs	NULL
with	NULL
novel	NULL
55	NULL
ends	NULL
.	NULL

Hence	NULL
,	NULL
one	NULL
or	NULL
more	NULL
basal	NULL
transcriptional	NULL
elements	NULL
are	NULL
situated	NULL
in	NULL
the	NULL
region	NULL
from	NULL
-30	NULL
to	NULL
+8	NULL
,	NULL
regulating	NULL
the	NULL
level	NULL
and	NULL
site	NULL
of	NULL
transcription	NULL
initiation	NULL
.	NULL

Preliminary	NULL
studies	NULL
have	NULL
identified	NULL
a	NULL
number	NULL
of	NULL
binding	NULL
activities	NULL
within	NULL
this	NULL
region	NULL
(	NULL
61a	NULL
)	NULL
.	NULL

Possible	NULL
mechanisms	NULL
involved	NULL
in	NULL
Thy-7	NULL
promoter	NULL
activation	NULL
.	NULL

The	NULL
individual	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

The	NULL
dominant	NULL
distal	NULL
elements	NULL
are	NULL
the	NULL
inverted	NULL
CCAAT	NULL
box	NULL
at	NULL
-85	NULL
to	NULL
-75	NULL
and	NULL
transcription	NULL
factor	NULL
CPI	NULL
that	NULL
binds	NULL
to	NULL
it	NULL
,	NULL
the	NULL
Spl	NULL
binding	NULL
site	NULL
at	NULL
-63	NULL
to	NULL
-56	NULL
,	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
the	NULL
Spl	NULL
site	NULL
at	NULL
-41	NULL
to	NULL
-33	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
CCAAT	NULL
box	NULL
in	NULL
a	NULL
promoter	NULL
without	NULL
a	NULL
TATA	NULL
box	NULL
is	NULL
a	NULL
rather	NULL
uncommon	NULL
motif	NULL
in	NULL
this	NULL
class	NULL
of	NULL
promoters	NULL
.	NULL

Tissue-specific	NULL
promoters	NULL
without	NULL
a	NULL
TATA	NULL
motif	NULL
constitute	NULL
10	NULL
to	NULL
20	NULL
%	NULL
of	NULL
the	NULL
published	NULL
promoter	NULL
sequences	NULL
.	NULL

Those	NULL
containing	NULL
an	NULL
HTF	NULL
island	NULL
and	NULL
a	NULL
CAAT	NULL
box	NULL
in	NULL
addition	NULL
constitute	NULL
less	NULL
than	NULL
1	NULL
%	NULL
(	NULL
61a	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
coordinated	NULL
interactions	NULL
of	NULL
Spl	NULL
and	NULL
CCAAT-binding	NULL
proteins	NULL
with	NULL
additional	NULL
promoter	NULL
elements	NULL
was	NULL
initially	NULL
shown	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
38	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Both	NULL
elements	NULL
are	NULL
capable	NULL
of	NULL
activating	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

transcription	NULL
in	NULL
a	NULL
bidirectional	NULL
manner	NULL
(	NULL
22	NULL
,	NULL
50	NULL
)	NULL
.	NULL

In	NULL
the	NULL
Thy-/	NULL
promoter	NULL
,	NULL
Spl	NULL
and	NULL
CPI	NULL
bind	NULL
independently	NULL
of	NULL
each	NULL
other	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
competition	NULL
footprinting	NULL
assays	NULL
.	NULL

The	NULL
structural	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
shows	NULL
that	NULL
CP1	NULL
and	NULL
Spl	NULL
along	NULL
with	NULL
the	NULL
proximal	NULL
elements	NULL
are	NULL
essential	NULL
for	NULL
promoter	NULL
function	NULL
.	NULL

However	NULL
,	NULL
both	NULL
in	NULL
transgenic	NULL
mice	NULL
and	NULL
in	NULL
tissue	NULL
culture	NULL
lines	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
those	NULL
three	NULL
elements	NULL
fails	NULL
to	NULL
initiate	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
enhancer	NULL
sequences	NULL
.	NULL

Simi-larly	NULL
,	NULL
the	NULL
human	NULL
B-globin	NULL
and	NULL
adenosine	NULL
deaminase	NULL
promoters	NULL
remain	NULL
inactive	NULL
when	NULL
introduced	NULL
into	NULL
cell	NULL
lines	NULL
and	NULL
transgenic	NULL
mice	NULL
,	NULL
respectively	NULL
(	NULL
1	NULL
,	NULL
26	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
implies	NULL
that	NULL
the	NULL
structural	NULL
arrangement	NULL
of	NULL
transcription	NULL
factors	NULL
bound	NULL
to	NULL
these	NULL
promoters	NULL
(	NULL
as	NULL
detected	NULL
by	NULL
the	NULL
in	NULL
vitro	NULL
binding	NULL
assays	NULL
)	NULL
does	NULL
not	NULL
allow	NULL
productive	NULL
interactions	NULL
unless	NULL
enhancer	NULL
sequences	NULL
are	NULL
provided	NULL
in	NULL
cis	NULL
,	NULL
even	NULL
though	NULL
in	NULL
vivo	NULL
transactivation	NULL
assays	NULL
indicate	NULL
that	NULL
factors	NULL
such	NULL
as	NULL
Spl	NULL
and	NULL
OTF-2	NULL
can	NULL
function	NULL
as	NULL
transcriptional	NULL
activators	NULL
of	NULL
minimal	NULL
promoters	NULL
(	NULL
TATA-cap	NULL
region	NULL
)	NULL
without	NULL
any	NULL
other	NULL
distal	NULL
elements	NULL
(	NULL
10	NULL
,	NULL
63	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Transcriptional	NULL
inactivity	NULL
of	NULL
the	NULL
Thy-/	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
enhancer	NULL
sequences	NULL
could	NULL
also	NULL
be	NULL
explained	NULL
if	NULL
the	NULL
promoter	NULL
remains	NULL
inaccessible	NULL
for	NULL
Spl	NULL
and	NULL
CPI	NULL
to	NULL
bind	NULL
.	NULL

Although	NULL
a	NULL
number	NULL
of	NULL
factors	NULL
can	NULL
be	NULL
complexed	NULL
to	NULL
the	NULL
Thy-/	NULL
promoter	NULL
in	NULL
vitro	NULL
,	NULL
that	NULL
might	NULL
not	NULL
be	NULL
the	NULL
case	NULL
in	NULL
vivo	NULL
because	NULL
of	NULL
a	NULL
nonpermissive	NULL
chromatin	NULL
configuration	NULL
.	NULL

At	NULL
this	NULL
stage	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
methylation	NULL
of	NULL
promoter	NULL
sequences	NULL
might	NULL
affect	NULL
its	NULL
activation	NULL
,	NULL
since	NULL
the	NULL
Thy-/	NULL
HTF	NULL
remains	NULL
methylation	NULL
free	NULL
in	NULL
nonexpressing	NULL
tissues	NULL
(	NULL
45	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
observed	NULL
cessation	NULL
in	NULL
transcription	NULL
after	NULL
artificial	NULL
methylation	NULL
of	NULL
the	NULL
Thy-/	NULL
HTF	NULL
(	NULL
61	NULL
)	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
Spl	NULL
binding	NULL
activity	NULL
,	NULL
since	NULL
Spl	NULL
binds	NULL
equally	NULL
well	NULL
to	NULL
methylated	NULL
sites	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Probably	NULL
more	NULL
important	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
CpG	NULL
islands	NULL
have	NULL
an	NULL
alternative	NULL
chromatin	NULL
structure	NULL
,	NULL
the	NULL
main	NULL
features	NULL
being	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
histone	NULL
H1	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
highly	NULL
acetylated	NULL
histones	NULL
H3	NULL
and	NULL
H4	NULL
,	NULL
and	NULL
finally	NULL
an	NULL
overrepresentation	NULL
of	NULL
nucleosome-free	NULL
areas	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Previous	NULL
experiments	NULL
in	NULL
transgenic	NULL
mice	NULL
have	NULL
shown	NULL
that	NULL
neuronal	NULL
and	NULL
thymic	NULL
Thy-1	NULL
expression	NULL
is	NULL
absolutely	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
downstream	NULL
enhancer	NULL
sequences	NULL
(	NULL
67	NULL
)	NULL
.	NULL

This	NULL
is	NULL
confirmed	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
Thy-//y-globin	NULL
hybrid	NULL
gene	NULL
,	NULL
which	NULL
shows	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
promoter	NULL
to	NULL
function	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
enhancer	NULL
sequences	NULL
or	NULL
to	NULL
confer	NULL
any	NULL
specificity	NULL
to	NULL
the	NULL
foreign	NULL
gene	NULL
.	NULL

The	NULL
alternative	NULL
explanation	NULL
for	NULL
this	NULL
result	NULL
is	NULL
a	NULL
dominant	NULL
suppression	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
the	NULL
nonexpressing	NULL
tissues	NULL
.	NULL

A	NULL
repressor	NULL
activity	NULL
was	NULL
implicated	NULL
in	NULL
cell	NULL
fusion	NULL
experiments	NULL
between	NULL
Thy-/-positive	NULL
and	NULL
-negative	NULL
cell	NULL
lines	NULL
(	NULL
31	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Elimination	NULL
of	NULL
different	NULL
Thy-/	NULL
sequences	NULL
(	NULL
upstream	NULL
of	NULL
-270	NULL
or	NULL
downstream	NULL
of	NULL
+36	NULL
)	NULL
did	NULL
not	NULL
result	NULL
in	NULL
a	NULL
reproducible	NULL
gain	NULL
of	NULL
expression	NULL
in	NULL
the	NULL
negative	NULL
tissues	NULL
(	NULL
67	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
a	NULL
potential	NULL
repressor	NULL
function	NULL
could	NULL
be	NULL
present	NULL
only	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
region	NULL
between	NULL
-50	NULL
and	NULL
-41	NULL
of	NULL
the	NULL
Thy-1	NULL
promoter	NULL
shows	NULL
homology	NULL
in	NULL
eight	NULL
of	NULL
nine	NULL
nucleotides	NULL
with	NULL
a	NULL
silencer	NULL
sequence	NULL
found	NULL
in	NULL
the	NULL
human	NULL
e-globin	NULL
gene	NULL
(	NULL
6	NULL
)	NULL
and	NULL
the	NULL
chicken	NULL
lysozyme	NULL
box	NULL
1	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
deletion	NULL
of	NULL
this	NULL
sequence	NULL
in	NULL
the	NULL
mutant	NULL
ID	NULL
-52/-31	NULL
leads	NULL
to	NULL
fourfold	NULL
stimulation	NULL
of	NULL
transcription	NULL
(	NULL
compared	NULL
with	NULL
LS	NULL
-41/-31	NULL
)	NULL
when	NULL
assayed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
enhancer	NULL
sequences	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
Thy-/	NULL
promoter	NULL
functions	NULL
through	NULL
the	NULL
coordinated	NULL
interaction	NULL
of	NULL
the	NULL
two	NULL
transcription	NULL
factors	NULL
CP1	NULL
and	NULL
Sp1	NULL
and	NULL
the	NULL
proximal	NULL
promoter	NULL
elements	NULL
.	NULL

However	NULL
,	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
promoter	NULL
does	NULL
not	NULL
permit	NULL
productive	NULL
interactions	NULL
between	NULL
the	NULL
different	NULL
factors	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
cis-acting	NULL
enhancer	NULL
sequences	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
repressor	NULL
activity	NULL
.	NULL

Tissue	NULL
specificity	NULL
is	NULL
conferred	NULL
by	NULL
the	NULL
downstream	NULL
elements	NULL
,	NULL
and	NULL
therefore	NULL
the	NULL
Vor	NULL
.	NULL

11	NULL
,	NULL
1991	NULL
promoter	NULL
acts	NULL
as	NULL
the	NULL
mediator	NULL
rather	NULL
than	NULL
the	NULL
primary	NULL
activator	NULL
of	NULL
transcription	NULL
initiation	NULL
.	NULL

The	NULL
extensive	NULL
analysis	NULL
of	NULL
promoter	NULL
mutants	NULL
in	NULL
transgenic	NULL
mice	NULL
might	NULL
uncover	NULL
the	NULL
mechanisms	NULL
underlying	NULL
transcriptional	NULL
activation	NULL
in	NULL
the	NULL
Thy-1	NULL
gene	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
N.	NULL
Yannoutsos	NULL
for	NULL
generating	NULL
the	NULL
transgenic	NULL
mice	NULL
lines	NULL
,	NULL
S.	NULL
Jackson	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
Spl	NULL
polyclonal	NULL
antibodies	NULL
,	NULL
P.	NULL
Rigby	NULL
and	NULL
D.	NULL
Kioussis	NULL
for	NULL
helpful	NULL
suggestions	NULL
,	NULL
and	NULL
Cora	NULL
O'Carroll	NULL
for	NULL
assistance	NULL
in	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

E.S	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
the	NULL
Greek	NULL
State	NULL
Scholarship	NULL
Foundation	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

REFERENCES	NULL
.	NULL

Aronow	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
Lattier	NULL
,	NULL
R.	NULL
Silbiger	NULL
,	NULL
N.	NULL
Dusing	NULL
,	NULL
J.	NULL
Hutton	NULL
,	NULL
G.	NULL
Jones	NULL
,	NULL
J	NULL
.	NULL

Stock	NULL
,	NULL
J.	NULL
McNeish	NULL
,	NULL
S.	NULL
Potter	NULL
,	NULL
D.	NULL
Witte	NULL
,	NULL
and	NULL
D.	NULL
Wigin-ton	NULL
.	NULL

1989	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
complex	NULL
regulatory	NULL
array	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
of	NULL
the	NULL
human	NULL
adenosine	NULL
deaminase	NULL
gene	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1384-1400.	NULL
.	NULL

Baniahmad	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
C.	NULL
Steiner	NULL
,	NULL
and	NULL
R.	NULL
Renkawitz	NULL
.	NULL

1987	NULL
.	NULL

Activity	NULL
of	NULL
two	NULL
different	NULL
silencer	NULL
elements	NULL
of	NULL
the	NULL
chicken	NULL
lysozyme	NULL
gene	NULL
can	NULL
be	NULL
compensated	NULL
by	NULL
enhancer	NULL
elements	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:2297-2303.	NULL
.	NULL

Basler	NULL
,	NULL
K.	NULL
,	NULL
P.	NULL
Siegrist	NULL
,	NULL
and	NULL
E.	NULL
Hafen	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
spatial	NULL
and	NULL
temporal	NULL
expression	NULL
pattern	NULL
of	NULL
sevenless	NULL
is	NULL
exclusively	NULL
controlled	NULL
by	NULL
gene-internal	NULL
elements	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:2381-2386.	NULL
.	NULL

Bird	NULL
,	NULL
A	NULL
.	NULL

1986	NULL
.	NULL

CpG-rich	NULL
islands	NULL
and	NULL
the	NULL
function	NULL
of	NULL
DNA	NULL
methylation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
321:209-213.	NULL
.	NULL

Briggs	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
S.	NULL
P.	NULL
Bell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Purification	NULL
and	NULL
biochemical	NULL
characterization	NULL
of	NULL
the	NULL
promoter-specific	NULL
transcription	NULL
factor	NULL
,	NULL
Spl	NULL
.	NULL

Science	NULL
234:47-52.	NULL
.	NULL

Cao	NULL
,	NULL
S.	NULL
X.	NULL
,	NULL
P.	NULL
D.	NULL
Gutman	NULL
,	NULL
H.	NULL
P.	NULL
G.	NULL
Dave	NULL
,	NULL
and	NULL
A.	NULL
N.	NULL
Schechter	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
transcriptional	NULL
silencer	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
e-globin	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:5306-5309.	NULL
.	NULL

Chen	NULL
,	NULL
S.	NULL
,	NULL
F.	NULL
Botteri	NULL
,	NULL
H.	NULL
van	NULL
der	NULL
Putten	NULL
,	NULL
C.	NULL
R.	NULL
Landel	NULL
,	NULL
and	NULL
G.	NULL
Evans	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
lymphoproliferative	NULL
abnormality	NULL
associated	NULL
with	NULL
inappropriate	NULL
expression	NULL
of	NULL
the	NULL
Thy-1	NULL
antigen	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
51:7-19.	NULL
.	NULL

Chodosh	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Baldwin	NULL
,	NULL
R.	NULL
Carthew	NULL
,	NULL
and	NULL
P.	NULL
Sharp	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
CCAAT-binding	NULL
proteins	NULL
have	NULL
heterologous	NULL
subunits	NULL
.	NULL

Cell	NULL
53:11-24.	NULL
.	NULL

Clevers	NULL
,	NULL
H.	NULL
,	NULL
N.	NULL
Lonberg	NULL
,	NULL
S.	NULL
Dunlap	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
C.	NULL
Terhorst	NULL
.	NULL

1989	NULL
.	NULL

An	NULL
enhancer	NULL
located	NULL
in	NULL
a	NULL
CpG-island	NULL
3	NULL
'	NULL
to	NULL
the	NULL
TCR/CD3-e	NULL
gene	NULL
confers	NULL
T	NULL
lymphocyte-specificity	NULL
to	NULL
its	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:2527-2535	NULL
.	NULL

Courey	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
D.	NULL
A.	NULL
Holtzman	NULL
,	NULL
S.	NULL
P.	NULL
Jackson	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Synergistic	NULL
activation	NULL
by	NULL
the	NULL
glutamine-rich	NULL
domains	NULL
of	NULL
human	NULL
transcription	NULL
factor	NULL
Sp1	NULL
.	NULL

Cell	NULL
59:827-836	NULL
.	NULL

Courey	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

Analysis	NULL
of	NULL
Spl	NULL
in	NULL
vivo	NULL
reveals	NULL
multiple	NULL
transcriptional	NULL
domains	NULL
,	NULL
including	NULL
a	NULL
novel	NULL
glutamine-rich	NULL
activation	NULL
motif	NULL
.	NULL

Cell	NULL
55:887-898	NULL
.	NULL

Dailey	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
M.	NULL
Hanly	NULL
,	NULL
R.	NULL
G.	NULL
Roeder	NULL
,	NULL
and	NULL
N.	NULL
Heintz	NULL
.	NULL

1986	NULL
.	NULL

Distinct	NULL
transcription	NULL
factors	NULL
bind	NULL
specifically	NULL
to	NULL
two	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
histone	NULL
H4	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:7241-7245	NULL
.	NULL

Dailey	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
B.	NULL
Roberts	NULL
,	NULL
and	NULL
N.	NULL
Heintz	NULL
.	NULL

1988	NULL
.	NULL

Purification	NULL
of	NULL
the	NULL
human	NULL
histone	NULL
H4	NULL
gene-specific	NULL
transcription	NULL
factors	NULL
H4TF-1	NULL
and	NULL
H4TF-2	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1700-1712	NULL
.	NULL

Dawson	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
S.	NULL
L.	NULL
Hofmann	NULL
,	NULL
D.	NULL
R.	NULL
van	NULL
der	NULL
Westhuyzen	NULL
,	NULL
T.	NULL
C.	NULL
Sudhof	NULL
,	NULL
M.	NULL
S.	NULL
Brown	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Goldstein	NULL
.	NULL

1988	NULL
.	NULL

Sterol-depen-dent	NULL
repression	NULL
of	NULL
low	NULL
density	NULL
lipoprotein	NULL
receptor	NULL
promoter	NULL
mediated	NULL
by	NULL
16-base	NULL
pair	NULL
sequence	NULL
adjacent	NULL
to	NULL
binding	NULL
site	NULL
for	NULL
transcription	NULL
factor	NULL
Spl	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:3372-3379.	NULL
de	NULL
Boer	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Antoniou	NULL
,	NULL
V.	NULL
Mignotte	NULL
,	NULL
L.	NULL
Wall	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
human	NULL
B-globin	NULL
promoter	NULL
;	NULL
nuclear	NULL
protein	NULL
factors	NULL
and	NULL
erythroid	NULL
specific	NULL
induction	NULL
of	NULL
transcription	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:4203-4212	NULL
.	NULL

DETAILED	NULL
ANALYSIS	NULL
OF	NULL
THE	NULL
MURINE	NULL
Thy-/	NULL
GENE	NULL
PROMOTER	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

33a	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

2227	NULL
Dignam	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Lebowitz	NULL
,	NULL
and	NULL
R.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Dorn	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Bollekens	NULL
,	NULL
A.	NULL
Staub	NULL
,	NULL
C.	NULL
Benoist	NULL
,	NULL
and	NULL
D.	NULL
Mathis	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
multiplicity	NULL
of	NULL
CAAT-box	NULL
binding	NULL
proteins	NULL
.	NULL

Cell	NULL
50:863-872	NULL
.	NULL

Dynan	NULL
,	NULL
S.	NULL
W.	NULL
1986	NULL
.	NULL

Promoters	NULL
of	NULL
housekeeping	NULL
genes	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

6:196-197	NULL
.	NULL

Gardiner-Garden	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
Frommer	NULL
.	NULL

1987	NULL
.	NULL

CpG	NULL
islands	NULL
in	NULL
vertebrate	NULL
genomes	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

196:261-282	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
P.	NULL
van	NULL
den	NULL
Elsen	NULL
,	NULL
E.	NULL
Bier	NULL
,	NULL
A.	NULL
Maxam	NULL
,	NULL
and	NULL
C.	NULL
Terhorst	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
T-cell	NULL
specific	NULL
enhancer	NULL
is	NULL
located	NULL
in	NULL
a	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
area	NULL
at	NULL
the	NULL
3	NULL
'	NULL
of	NULL
the	NULL
CD3-8	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:2401-2407	NULL
.	NULL

Gidoni	NULL
,	NULL
D.	NULL
,	NULL
W.	NULL
S.	NULL
Dynan	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1984	NULL
.	NULL

Multiple	NULL
specific	NULL
contacts	NULL
between	NULL
a	NULL
mammalian	NULL
transcription	NULL
factor	NULL
and	NULL
its	NULL
cognate	NULL
promoters	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
312:409-413	NULL
.	NULL

Gidoni	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
H.	NULL
Barrera-Saldana	NULL
,	NULL
K.	NULL
Takahashi	NULL
,	NULL
P.	NULL
Chambon	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1985	NULL
.	NULL

Bidirectional	NULL
SV40	NULL
transcription	NULL
mediated	NULL
by	NULL
tandem	NULL
Spl	NULL
binding	NULL
interactions	NULL
.	NULL

Science	NULL
230:511-517	NULL
.	NULL

Giguere	NULL
,	NULL
V.	NULL
,	NULL
K.-I	NULL
.	NULL

Isobe	NULL
,	NULL
and	NULL
F.	NULL
G.	NULL
Grosveld	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
murine	NULL
Thy-1	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4:2017-2024	NULL
.	NULL

Gorski	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Carneiro	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1986	NULL
.	NULL

Tissue-specific	NULL
in	NULL
vitro	NULL
transcription	NULL
from	NULL
the	NULL
mouse	NULL
albumin	NULL
promoter	NULL
.	NULL

Cell	NULL
47:767-776	NULL
.	NULL

Graves	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
P.	NULL
F.	NULL
Johnson	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1986	NULL
.	NULL

Homologous	NULL
recognition	NULL
of	NULL
a	NULL
promoter	NULL
domain	NULL
common	NULL
to	NULL
the	NULL
MSV	NULL
LTR	NULL
and	NULL
the	NULL
HSV	NULL
tk	NULL
gene	NULL
.	NULL

Cell	NULL
44:565-576	NULL
.	NULL

Green	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
R.	NULL
Treisman	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1983	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
cloned	NULL
human	NULL
B-globin	NULL
genes	NULL
by	NULL
viral	NULL
immediate-early	NULL
gene	NULL
products	NULL
.	NULL

Cell	NULL
.	NULL

35:137-148	NULL
.	NULL

Gustafson	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
L.	NULL
Kedes	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
of	NULL
multiple	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
functional	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
cardiac	NULL
«	NULL
-actin	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:3269-3283	NULL
.	NULL

Harrington	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
P.	NULL
A.	NULL
Jones	NULL
,	NULL
M.	NULL
Imagawa	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1988	NULL
.	NULL

Cytosine	NULL
methylation	NULL
does	NULL
not	NULL
affect	NULL
binding	NULL
of	NULL
transcription	NULL
factor	NULL
Spl	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:2066-2070	NULL
.	NULL

Holler	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Westin	NULL
,	NULL
J.	NULL
Jirieny	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1988	NULL
.	NULL

Spl	NULL
transcription	NULL
factor	NULL
binds	NULL
DNA	NULL
and	NULL
activates	NULL
transcription	NULL
even	NULL
when	NULL
the	NULL
binding	NULL
site	NULL
is	NULL
CpG	NULL
methylated	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1127-1135	NULL
.	NULL

Huang	NULL
,	NULL
H.-C.	NULL
,	NULL
R.	NULL
Sundseth	NULL
,	NULL
and	NULL
U.	NULL
Hansen	NULL
.	NULL

1990	NULL
.	NULL

Transcription	NULL
factor	NULL
LSF	NULL
binds	NULL
two	NULL
variant	NULL
bipartite	NULL
sites	NULL
within	NULL
the	NULL
SV40	NULL
late	NULL
promoter	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:287-298	NULL
.	NULL

Hyman	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
V.	NULL
Stallings	NULL
.	NULL

1978	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
gene	NULL
extinguishing	NULL
cell-surface	NULL
expression	NULL
of	NULL
the	NULL
Thy-1	NULL
antigen	NULL
.	NULL

Immuno-genetics	NULL
6:447-458	NULL
.	NULL

Imagawa	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1987	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-2	NULL
mediates	NULL
induction	NULL
by	NULL
two	NULL
different	NULL
signal-transduction	NULL
pathways	NULL
:	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
cAMP	NULL
.	NULL

Cell	NULL
51:251-260	NULL
.	NULL

Ingraham	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Evans	NULL
.	NULL

1986	NULL
.	NULL

Characterization	NULL
of	NULL
two	NULL
atypical	NULL
promoters	NULL
and	NULL
alternate	NULL
mRNA	NULL
processing	NULL
in	NULL
the	NULL
mouse	NULL
Thy-1.2	NULL
glycoprotein	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:2923-2931	NULL
.	NULL

Jackson	NULL
,	NULL
S.	NULL
Personal	NULL
communication	NULL
.	NULL

Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

Unexpected	NULL
O-glycosylation	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
:	NULL
implications	NULL
for	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Cell	NULL
§5:125-133	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
W.	NULL
H.	NULL
Landschulz	NULL
,	NULL
B.	NULL
J.	NULL
Graves	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
rat	NULL
liver	NULL
nuclear	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
enhancer	NULL
core	NULL
element	NULL
of	NULL
three	NULL
animal	NULL
viruses	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:133-146	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Eukaryotic	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58:799-839	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
P.	NULL
J.	NULL
Rosenfeld	NULL
,	NULL
T.	NULL
J.	NULL
Kelly	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
cellular	NULL
DNA-binding	NULL
protein	NULL
that	NULL
activates	NULL
eukaryotic	NULL
transcription	NULL
and	NULL
DNA	NULL
replication	NULL
.	NULL

Cell	NULL
48:79-89	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
K.	NULL
R.	NULL
Yamamoto	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1985	NULL
.	NULL

Two	NULL
distinct	NULL
transcription	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
HSV	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
42:559-572	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
K.	NULL
R.	NULL
Carner	NULL
,	NULL
F.	NULL
R.	NULL
Masiarz	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Isolation	NULL
of	NULL
cDNA	NULL
encoding	NULL
transcription	NULL
factor	NULL
Spl	NULL
and	NULL
2228	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

SPANOPOULOU	NULL
ET	NULL
AL	NULL
.	NULL

functional	NULL
analysis	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Cell	NULL
51:1079-1090.	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
A.	NULL
J.	NULL
Courey	NULL
,	NULL
J.	NULL
Ladika	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

Distinct	NULL
regions	NULL
of	NULL
Spl	NULL
modulate	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
.	NULL

Science	NULL
242:1566-1570	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
K.	NULL
A.	NULL
Jones	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Promoter-specific	NULL
activation	NULL
of	NULL
RNA	NULL
polymerasell	NULL
transcription	NULL
by	NULL
Spl	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

11:20-23	NULL
.	NULL

Kageyama	NULL
,	NULL
R.	NULL
,	NULL
G.	NULL
T.	NULL
Merlino	NULL
,	NULL
and	NULL
I.	NULL
Pastan	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
transcription	NULL
factor	NULL
active	NULL
on	NULL
the	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:5016-5020	NULL
.	NULL

Kageyama	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
I.	NULL
Pastan	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
DNA	NULL
binding	NULL
factor	NULL
that	NULL
represses	NULL
transcription	NULL
.	NULL

Cell	NULL
59:815-825.	NULL
.	NULL

Kollias	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Spanopoulou	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
M.	NULL
Ritter	NULL
,	NULL
J.	NULL
Beech	NULL
,	NULL
and	NULL
R.	NULL
Morris	NULL
.	NULL

1987	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
a	NULL
Thy-1	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:1492-1496	NULL
.	NULL

Kolsto	NULL
,	NULL
A.-B	NULL
.	NULL

,	NULL
G.	NULL
Kollias	NULL
,	NULL
V.	NULL
Giguere	NULL
,	NULL
K.-L.	NULL
Isobe	NULL
,	NULL
H.	NULL
Prydz	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
maintenance	NULL
of	NULL
methylation-free	NULL
islands	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:9667-9778.	NULL
.	NULL

Letovsky	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
W.	NULL
S.	NULL
Dynan	NULL
.	NULL

1989	NULL
.	NULL

Measurement	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
transcription	NULL
factor	NULL
Spl	NULL
to	NULL
a	NULL
single	NULL
GC	NULL
box	NULL
recognition	NULL
sequence	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:2639-2653	NULL
.	NULL

Low	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Kincade	NULL
.	NULL

1988	NULL
.	NULL

Phosphatidy	NULL
]	NULL
inositol	NULL
in	NULL
the	NULL
membrane	NULL
anchoring	NULL
domain	NULL
of	NULL
the	NULL
Thy-1	NULL
glycoprotein	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
318:62-65	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1980	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavage	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65	NULL
:	NULL
499-560	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
R.	NULL
Kingsbury	NULL
.	NULL

1982	NULL
.	NULL

Transcriptional	NULL
control	NULL
signals	NULL
of	NULL
a	NULL
eukaryotic	NULL
protein-encoding	NULL
gene	NULL
.	NULL

Science	NULL
217:316-324	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
R.	NULL
C.	NULL
Kingsbury	NULL
,	NULL
A.	NULL
Spence	NULL
,	NULL
and	NULL
M.	NULL
Smith	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
distal	NULL
transcription	NULL
signals	NULL
of	NULL
the	NULL
herpes	NULL
virus	NULL
tk	NULL
gene	NULL
share	NULL
a	NULL
common	NULL
hexanucleotide	NULL
control	NULL
sequence	NULL
.	NULL

Cell	NULL
.	NULL

37:253-262	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Transcriptional	NULL
selectivity	NULL
of	NULL
viral	NULL
genes	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Cell	NULL
46:795-805	NULL
.	NULL

Mermod	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
J.	NULL
Williams	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Enhancer	NULL
binding	NULL
factors	NULL
AP-4	NULL
and	NULL
AP-1	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
activate	NULL
SV40	NULL
late	NULL
transcripts	NULL
in	NULL
vitro	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
332:557-560	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
C.	NULL
Wang	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
transcription	NULL
in	NULL
vitro	NULL
:	NULL
enhancer-binding	NULL
protein	NULL
AP-2	NULL
is	NULL
inhibited	NULL
by	NULL
SV40	NULL
T-antigen	NULL
.	NULL

Cell	NULL
50:847-861	NULL
.	NULL

Morris	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

1985	NULL
.	NULL

Thy-1	NULL
in	NULL
developing	NULL
nervous	NULL
tissue	NULL
.	NULL

Dev	NULL
.	NULL

Neurosci	NULL
.	NULL

7:133-160	NULL
.	NULL

Morris	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
Thy-1	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
of	NULL
the	NULL
rat	NULL
and	NULL
mouse	NULL
,	NULL
p.	NULL
121-148	NULL
.	NULL

In	NULL
A.	NULL
E.	NULL
Reif	NULL
and	NULL
M.	NULL
Schlesinger	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Cell	NULL
surface	NULL
antigen	NULL
Thy-1	NULL
.	NULL

Marcel	NULL
Dekker	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
1986	NULL
.	NULL

Gene	NULL
regulation	NULL
by	NULL
proteins	NULL
acting	NULL
nearby	NULL
and	NULL
at	NULL
a	NULL
distance	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
322:697-701	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Reif	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
Allen	NULL
.	NULL

1964	NULL
.	NULL

The	NULL
AKR	NULL
thymic	NULL
antigen	NULL
and	NULL
its	NULL
distribution	NULL
in	NULL
leukemias	NULL
and	NULL
nervous	NULL
tissues	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

120:413-433	NULL
.	NULL

Saleh	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Bartlett	NULL
.	NULL

1989	NULL
.	NULL

Evidence	NULL
from	NULL
neuronal	NULL
heterokaryons	NULL
for	NULL
a	NULL
trans-acting	NULL
factor	NULL
suppressing	NULL
Thy-1	NULL
expression	NULL
during	NULL
neuronal	NULL
development	NULL
.	NULL

J.	NULL
Neurol	NULL
.	NULL

Sci	NULL
.	NULL

23	NULL
:	NULL
406-415	NULL
.	NULL

Santoro	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
Mermod	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
family	NULL
of	NULL
CAAT	NULL
proteins	NULL
active	NULL
in	NULL
transcription	NULL
and	NULL
DNA	NULL
replication	NULL
:	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
multiple	NULL
cDNAs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334:218-224	NULL
.	NULL

Sehgal	NULL
,	NULL
A.	NULL
,	NULL
N.	NULL
Patil	NULL
,	NULL
and	NULL
M.	NULL
Chao	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
constitutive	NULL
promoter	NULL
directs	NULL
expression	NULL
of	NULL
the	NULL
nerve	NULL
growth	NULL
factor	NULL
receptor	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:352-362	NULL
.	NULL

Sneller	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
K.	NULL
Gunter	NULL
.	NULL

1987	NULL
.	NULL

DNA	NULL
methylation	NULL
alters	NULL
chromatin	NULL
structure	NULL
and	NULL
regulates	NULL
THY-1	NULL
expression	NULL
in	NULL
EL-4	NULL
T-cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:3505-3512	NULL
.	NULL

61a.Spanopoulou	NULL
,	NULL
E.	NULL
Unpublished	NULL
data	NULL
.	NULL

61b.Spanopoulou	NULL
,	NULL
E.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

Spanopoulou	NULL
,	NULL
E.	NULL
,	NULL
V.	NULL
Giguere	NULL
,	NULL
and	NULL
F.	NULL
G.	NULL
Grosveld	NULL
.	NULL

1988	NULL
.	NULL

Transcriptional	NULL
unit	NULL
of	NULL
the	NULL
murine	NULL
Thy-1	NULL
gene	NULL
:	NULL
different	NULL
distribution	NULL
of	NULL
transcription	NULL
initiation	NULL
sites	NULL
in	NULL
brain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:3847-3856	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Grossniklaus	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
N.	NULL
Hernandez	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
U2	NULL
sn	NULL
RNA	NULL
promoter	NULL
by	NULL
the	NULL
octamer	NULL
motif	NULL
defines	NULL
a	NULL
new	NULL
class	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
enhancer	NULL
elements	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2:1764-1778.	NULL
.	NULL

Tazi	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
Bird	NULL
.	NULL

1990	NULL
.	NULL

Alternative	NULL
chromatin	NULL
structure	NULL
at	NULL
CpG	NULL
islands	NULL
.	NULL

Cell	NULL
60:909-920	NULL
.	NULL

Thali	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
M.	NULL
DeLorenzi	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
and	NULL
M.	NULL
Bienz	NULL
.	NULL

1988	NULL
.	NULL

Drosophila	NULL
homeotic	NULL
genes	NULL
encode	NULL
transcriptional	NULL
activators	NULL
similar	NULL
to	NULL
mammalian	NULL
OTF-2	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
336:598-601.	NULL
.	NULL

Tse	NULL
,	NULL
A.	NULL
G.	NULL
C.	NULL
,	NULL
A.	NULL
N.	NULL
Barclay	NULL
,	NULL
A.	NULL
Watts	NULL
,	NULL
and	NULL
A.	NULL
F.	NULL
Williams	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
glycophospholipid	NULL
tail	NULL
at	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
the	NULL
Thy-1	NULL
glycoprotein	NULL
of	NULL
neurons	NULL
and	NULL
thymocytes	NULL
.	NULL

Science	NULL
330:1003-1009	NULL
.	NULL

Vidal	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Morris	NULL
,	NULL
F.	NULL
G.	NULL
Grosveld	NULL
,	NULL
and	NULL
E.	NULL
Spanopoulou	NULL
.	NULL

1990	NULL
.	NULL

Tissue	NULL
specific	NULL
control	NULL
elements	NULL
of	NULL
the	NULL
Thy-1	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:833-840	NULL
.	NULL

Westin	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
zinc-responsive	NULL
factor	NULL
interacts	NULL
with	NULL
a	NULL
metal-regulated	NULL
enhancer	NULL
element	NULL
(	NULL
MRE	NULL
)	NULL
of	NULL
the	NULL
mouse	NULL
metallothionein-I	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:3763-3770	NULL
.	NULL

Whitelaw	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Hogben	NULL
,	NULL
O.	NULL
Hanscombe	NULL
,	NULL
and	NULL
N.	NULL
J.	NULL
Proudfoot	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
promiscuity	NULL
of	NULL
the	NULL
human	NULL
a-globin	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:241-251	NULL
.	NULL

Williams	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
Gagnon	NULL
.	NULL

1982	NULL
.	NULL

Neuronal	NULL
cell	NULL
Thy-1	NULL
glyco-protein	NULL
:	NULL
homology	NULL
with	NULL
immunoglobulin	NULL
.	NULL

Science	NULL
216:696-703	NULL
.	NULL

Xiao	NULL
,	NULL
J.-H.	NULL
,	NULL
I.	NULL
Davidson	NULL
,	NULL
M.	NULL
Macchi	NULL
,	NULL
R.	NULL
Rosales	NULL
,	NULL
M.	NULL
Vigneron	NULL
,	NULL
A.	NULL
Staub	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1987	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
of	NULL
several	NULL
cell-specific	NULL
and	NULL
ubiquitous	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
GT-I	NULL
motif	NULL
of	NULL
the	NULL
SV-40	NULL
enhancer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1	NULL
;	NULL
794-807	NULL
.	NULL

